NO317631B1 - Oksygeninneholdende heterocykliske forbindelser - Google Patents
Oksygeninneholdende heterocykliske forbindelser Download PDFInfo
- Publication number
- NO317631B1 NO317631B1 NO19970151A NO970151A NO317631B1 NO 317631 B1 NO317631 B1 NO 317631B1 NO 19970151 A NO19970151 A NO 19970151A NO 970151 A NO970151 A NO 970151A NO 317631 B1 NO317631 B1 NO 317631B1
- Authority
- NO
- Norway
- Prior art keywords
- compound
- substituted
- methoxy
- nmr
- ppm
- Prior art date
Links
- 229910052760 oxygen Inorganic materials 0.000 title claims abstract description 21
- 150000002391 heterocyclic compounds Chemical class 0.000 title claims abstract description 13
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 title claims abstract description 11
- 239000001301 oxygen Substances 0.000 title claims abstract description 11
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 48
- 239000001257 hydrogen Substances 0.000 claims abstract description 47
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims abstract description 44
- 125000003118 aryl group Chemical group 0.000 claims abstract description 40
- 150000002431 hydrogen Chemical class 0.000 claims abstract description 40
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 35
- 150000003839 salts Chemical class 0.000 claims abstract description 29
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 25
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 22
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims abstract description 12
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 10
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 8
- 150000002367 halogens Chemical class 0.000 claims abstract description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 8
- 150000001721 carbon Chemical group 0.000 claims abstract description 4
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims abstract description 4
- ILVXOBCQQYKLDS-UHFFFAOYSA-N pyridine N-oxide Chemical compound [O-][N+]1=CC=CC=C1 ILVXOBCQQYKLDS-UHFFFAOYSA-N 0.000 claims abstract description 4
- -1 quinozolinyl Chemical group 0.000 claims description 35
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 24
- 238000002360 preparation method Methods 0.000 claims description 22
- 125000001589 carboacyl group Chemical group 0.000 claims description 9
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims description 8
- 125000001424 substituent group Chemical group 0.000 claims description 8
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 7
- 125000000623 heterocyclic group Chemical group 0.000 claims description 7
- 230000002757 inflammatory effect Effects 0.000 claims description 7
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 7
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 6
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 6
- 229910052717 sulfur Inorganic materials 0.000 claims description 6
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims description 5
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 4
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 claims description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 4
- 208000026935 allergic disease Diseases 0.000 claims description 4
- 125000003831 tetrazolyl group Chemical group 0.000 claims description 4
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims description 3
- 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 claims description 3
- 125000002541 furyl group Chemical group 0.000 claims description 3
- 125000001072 heteroaryl group Chemical group 0.000 claims description 3
- 125000002883 imidazolyl group Chemical group 0.000 claims description 3
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 claims description 3
- 125000001041 indolyl group Chemical group 0.000 claims description 3
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims description 3
- 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 claims description 3
- 125000002971 oxazolyl group Chemical group 0.000 claims description 3
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 claims description 3
- 125000004193 piperazinyl group Chemical group 0.000 claims description 3
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 claims description 3
- 125000003373 pyrazinyl group Chemical group 0.000 claims description 3
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 3
- 125000002098 pyridazinyl group Chemical group 0.000 claims description 3
- 125000004076 pyridyl group Chemical group 0.000 claims description 3
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 3
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims description 3
- 125000000168 pyrrolyl group Chemical group 0.000 claims description 3
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims description 3
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 claims description 3
- 125000003039 tetrahydroisoquinolinyl group Chemical group C1(NCCC2=CC=CC=C12)* 0.000 claims description 3
- 125000004853 tetrahydropyridinyl group Chemical group N1(CCCC=C1)* 0.000 claims description 3
- 125000000147 tetrahydroquinolinyl group Chemical group N1(CCCC2=CC=CC=C12)* 0.000 claims description 3
- 125000000335 thiazolyl group Chemical group 0.000 claims description 3
- 125000001544 thienyl group Chemical group 0.000 claims description 3
- 125000001425 triazolyl group Chemical group 0.000 claims description 3
- 125000006727 (C1-C6) alkenyl group Chemical group 0.000 claims description 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 2
- ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical compound C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 claims description 2
- 125000001624 naphthyl group Chemical group 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 125000003107 substituted aryl group Chemical group 0.000 claims description 2
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 125000006527 (C1-C5) alkyl group Chemical group 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract description 3
- 125000006360 carbonyl amino methylene group Chemical group [H]N(C([*:1])=O)C([H])([H])[*:2] 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 description 908
- 238000000034 method Methods 0.000 description 295
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 270
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 185
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 183
- 239000000203 mixture Substances 0.000 description 178
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 171
- 238000002844 melting Methods 0.000 description 169
- 230000008018 melting Effects 0.000 description 169
- 239000000243 solution Substances 0.000 description 152
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 147
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 138
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 136
- 239000013078 crystal Substances 0.000 description 134
- 239000002904 solvent Substances 0.000 description 129
- 238000000921 elemental analysis Methods 0.000 description 126
- 238000003756 stirring Methods 0.000 description 117
- 239000000126 substance Substances 0.000 description 112
- 239000007787 solid Substances 0.000 description 111
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 99
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 96
- 238000006243 chemical reaction Methods 0.000 description 91
- 239000012044 organic layer Substances 0.000 description 87
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 86
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 78
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 76
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 75
- 238000010898 silica gel chromatography Methods 0.000 description 74
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 73
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 69
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 66
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 63
- 230000002829 reductive effect Effects 0.000 description 57
- 238000001816 cooling Methods 0.000 description 50
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 48
- 239000012442 inert solvent Substances 0.000 description 48
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 44
- 238000000605 extraction Methods 0.000 description 44
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 38
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 36
- 239000007864 aqueous solution Substances 0.000 description 36
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 36
- 230000008569 process Effects 0.000 description 33
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 30
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 29
- 238000010992 reflux Methods 0.000 description 28
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 27
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 26
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 26
- 238000009835 boiling Methods 0.000 description 26
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 24
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 23
- 239000012300 argon atmosphere Substances 0.000 description 23
- 229910052938 sodium sulfate Inorganic materials 0.000 description 23
- 235000011152 sodium sulphate Nutrition 0.000 description 23
- XSIHTGSZVFKCNB-UHFFFAOYSA-N 2-[4-[(3,5-dichloropyridin-4-yl)carbamoyl]-7-methoxy-2,3-dihydro-1-benzofuran-3-yl]acetic acid Chemical compound C1=2C(CC(O)=O)COC=2C(OC)=CC=C1C(=O)NC1=C(Cl)C=NC=C1Cl XSIHTGSZVFKCNB-UHFFFAOYSA-N 0.000 description 22
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 22
- 238000010438 heat treatment Methods 0.000 description 21
- 238000001914 filtration Methods 0.000 description 20
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 20
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 19
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 19
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 19
- 229920006395 saturated elastomer Polymers 0.000 description 19
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 19
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 18
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 18
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 18
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 16
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 16
- 239000003377 acid catalyst Substances 0.000 description 16
- 239000002585 base Substances 0.000 description 16
- 239000000706 filtrate Substances 0.000 description 15
- 235000017557 sodium bicarbonate Nutrition 0.000 description 15
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 15
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 14
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 14
- 238000004440 column chromatography Methods 0.000 description 14
- LEHBURLTIWGHEM-UHFFFAOYSA-N pyridinium chlorochromate Chemical compound [O-][Cr](Cl)(=O)=O.C1=CC=[NH+]C=C1 LEHBURLTIWGHEM-UHFFFAOYSA-N 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- AQRLNPVMDITEJU-UHFFFAOYSA-N triethylsilane Chemical compound CC[SiH](CC)CC AQRLNPVMDITEJU-UHFFFAOYSA-N 0.000 description 14
- 238000007796 conventional method Methods 0.000 description 13
- 239000000741 silica gel Substances 0.000 description 13
- 229910002027 silica gel Inorganic materials 0.000 description 13
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 12
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 12
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 12
- 229910015900 BF3 Inorganic materials 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 11
- FKNQCJSGGFJEIZ-UHFFFAOYSA-N 4-methylpyridine Chemical compound CC1=CC=NC=C1 FKNQCJSGGFJEIZ-UHFFFAOYSA-N 0.000 description 10
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 10
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 10
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 10
- 229910000027 potassium carbonate Inorganic materials 0.000 description 10
- 239000007858 starting material Substances 0.000 description 10
- 229940098779 methanesulfonic acid Drugs 0.000 description 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 9
- QYOUBIYWOYGIQG-UHFFFAOYSA-N 2-(3,5-dichloropyridin-4-yl)-1-(7-methoxy-2,2-dimethyl-3h-1-benzofuran-4-yl)ethanol Chemical compound C1=2CC(C)(C)OC=2C(OC)=CC=C1C(O)CC1=C(Cl)C=NC=C1Cl QYOUBIYWOYGIQG-UHFFFAOYSA-N 0.000 description 8
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 8
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 8
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 8
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 8
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 8
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 8
- 206010006482 Bronchospasm Diseases 0.000 description 7
- 229960000583 acetic acid Drugs 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 7
- 235000019341 magnesium sulphate Nutrition 0.000 description 7
- RIEKUNSZSAGWMV-UHFFFAOYSA-N methyl 2,2-diethyl-7-methoxy-3h-1-benzofuran-4-carboxylate Chemical compound COC1=CC=C(C(=O)OC)C2=C1OC(CC)(CC)C2 RIEKUNSZSAGWMV-UHFFFAOYSA-N 0.000 description 7
- LSEFCHWGJNHZNT-UHFFFAOYSA-M methyl(triphenyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(C)C1=CC=CC=C1 LSEFCHWGJNHZNT-UHFFFAOYSA-M 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- TVBIIGMNGQNEIR-UHFFFAOYSA-N 1-(7-methoxy-2,2-dimethyl-3h-1-benzofuran-4-yl)-2-pyridin-4-ylethanol Chemical compound C1=2CC(C)(C)OC=2C(OC)=CC=C1C(O)CC1=CC=NC=C1 TVBIIGMNGQNEIR-UHFFFAOYSA-N 0.000 description 6
- BKZNPJJHZSUNLN-UHFFFAOYSA-N 1-(7-methoxy-3-methyl-2,3-dihydro-1-benzofuran-4-yl)-2-pyridin-4-ylethanol Chemical compound C1=2C(C)COC=2C(OC)=CC=C1C(O)CC1=CC=NC=C1 BKZNPJJHZSUNLN-UHFFFAOYSA-N 0.000 description 6
- PAMIQIKDUOTOBW-UHFFFAOYSA-N 1-methylpiperidine Chemical compound CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 description 6
- GNFGRSPDOZRGOT-UHFFFAOYSA-N 2-(3,5-dichloropyridin-4-yl)-1-(7-methoxy-3-methyl-2,3-dihydro-1-benzofuran-4-yl)ethanol Chemical compound C1=2C(C)COC=2C(OC)=CC=C1C(O)CC1=C(Cl)C=NC=C1Cl GNFGRSPDOZRGOT-UHFFFAOYSA-N 0.000 description 6
- WADSJYLPJPTMLN-UHFFFAOYSA-N 3-(cycloundecen-1-yl)-1,2-diazacycloundec-2-ene Chemical compound C1CCCCCCCCC=C1C1=NNCCCCCCCC1 WADSJYLPJPTMLN-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- DRSHXJFUUPIBHX-UHFFFAOYSA-N COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 Chemical compound COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 DRSHXJFUUPIBHX-UHFFFAOYSA-N 0.000 description 6
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 6
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 6
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 6
- 230000002152 alkylating effect Effects 0.000 description 6
- 230000007885 bronchoconstriction Effects 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 6
- 230000001413 cellular effect Effects 0.000 description 6
- 239000003638 chemical reducing agent Substances 0.000 description 6
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical compound O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- QSTNLQHRINHPQI-UHFFFAOYSA-N ethyl 2-[4-(cyclohexylcarbamoyl)-7-methoxy-2,3-dihydro-1-benzofuran-3-yl]acetate Chemical compound CCOC(=O)CC1COC(C(=CC=2)OC)=C1C=2C(=O)NC1CCCCC1 QSTNLQHRINHPQI-UHFFFAOYSA-N 0.000 description 6
- 238000005984 hydrogenation reaction Methods 0.000 description 6
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 6
- QXOXUEFXRSIYSW-UHFFFAOYSA-N methyl 3-hydroxy-4-methoxybenzoate Chemical compound COC(=O)C1=CC=C(OC)C(O)=C1 QXOXUEFXRSIYSW-UHFFFAOYSA-N 0.000 description 6
- 239000006188 syrup Substances 0.000 description 6
- 235000020357 syrup Nutrition 0.000 description 6
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 6
- OIIOPWHTJZYKIL-PMACEKPBSA-N (5S)-5-[[[5-[2-chloro-3-[2-chloro-3-[6-methoxy-5-[[[(2S)-5-oxopyrrolidin-2-yl]methylamino]methyl]pyrazin-2-yl]phenyl]phenyl]-3-methoxypyrazin-2-yl]methylamino]methyl]pyrrolidin-2-one Chemical compound C1(=C(N=C(C2=C(C(C3=CC=CC(=C3Cl)C3=NC(OC)=C(N=C3)CNC[C@H]3NC(=O)CC3)=CC=C2)Cl)C=N1)OC)CNC[C@H]1NC(=O)CC1 OIIOPWHTJZYKIL-PMACEKPBSA-N 0.000 description 5
- LUGOQKBQBDIWOG-UHFFFAOYSA-N (7-methoxy-3-methyl-2,3-dihydro-1-benzofuran-4-yl)methanol Chemical compound COC1=CC=C(CO)C2=C1OCC2C LUGOQKBQBDIWOG-UHFFFAOYSA-N 0.000 description 5
- MMDDADZDEIQUCV-FNORWQNLSA-N (e)-3-(7-methoxyspiro[3h-1-benzofuran-2,1'-cyclopentane]-4-yl)prop-2-enoic acid Chemical compound O1C=2C(OC)=CC=C(\C=C\C(O)=O)C=2CC21CCCC2 MMDDADZDEIQUCV-FNORWQNLSA-N 0.000 description 5
- SRIAVDHKGDQVDJ-UHFFFAOYSA-N 1-(7-methoxy-2,2-dimethyl-3h-1-benzofuran-4-yl)-1-phenyl-2-pyridin-4-ylethanol Chemical compound C1=2CC(C)(C)OC=2C(OC)=CC=C1C(O)(C=1C=CC=CC=1)CC1=CC=NC=C1 SRIAVDHKGDQVDJ-UHFFFAOYSA-N 0.000 description 5
- IPGJCXDNNYOVSU-UHFFFAOYSA-N 1-(7-methoxy-3-methyl-2,3-dihydro-1-benzofuran-4-yl)-1-phenyl-2-pyridin-4-ylethanol Chemical compound C1=2C(C)COC=2C(OC)=CC=C1C(O)(C=1C=CC=CC=1)CC1=CC=NC=C1 IPGJCXDNNYOVSU-UHFFFAOYSA-N 0.000 description 5
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical group C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 description 5
- BDMSGDGWFPMBSE-UHFFFAOYSA-N 2-(2-ethylphenyl)-7-methoxy-1-benzofuran Chemical compound CCC1=CC=CC=C1C1=CC2=CC=CC(OC)=C2O1 BDMSGDGWFPMBSE-UHFFFAOYSA-N 0.000 description 5
- CTABUQWWQHGHEE-UHFFFAOYSA-N 2-(3,5-dichloropyridin-4-yl)-1-(2,2-diethyl-7-methoxy-3h-1-benzofuran-4-yl)ethanol Chemical compound O1C(CC)(CC)CC2=C1C(OC)=CC=C2C(O)CC1=C(Cl)C=NC=C1Cl CTABUQWWQHGHEE-UHFFFAOYSA-N 0.000 description 5
- CNSGQWCSYGTSPS-UHFFFAOYSA-N 2-(5-bromo-2-methoxyphenoxy)cyclohexan-1-one Chemical compound COC1=CC=C(Br)C=C1OC1C(=O)CCCC1 CNSGQWCSYGTSPS-UHFFFAOYSA-N 0.000 description 5
- BIUHJCSPFGAWEZ-UHFFFAOYSA-N 2-(5-bromo-2-methoxyphenoxy)cyclopentan-1-one Chemical compound COC1=CC=C(Br)C=C1OC1C(=O)CCC1 BIUHJCSPFGAWEZ-UHFFFAOYSA-N 0.000 description 5
- AFWARSKFAIKVPH-UHFFFAOYSA-N 2-(7-methoxy-1-benzofuran-2-yl)benzaldehyde Chemical compound O1C=2C(OC)=CC=CC=2C=C1C1=CC=CC=C1C=O AFWARSKFAIKVPH-UHFFFAOYSA-N 0.000 description 5
- ISIQAMHROGZHOV-UHFFFAOYSA-N 3,5-dichloropyridin-4-amine Chemical compound NC1=C(Cl)C=NC=C1Cl ISIQAMHROGZHOV-UHFFFAOYSA-N 0.000 description 5
- ILJUHJCUUOBOIN-BQYQJAHWSA-N 4-[(e)-2-(7-methoxy-2-phenyl-1-benzofuran-4-yl)ethenyl]pyridine Chemical compound C1=2C=C(C=3C=CC=CC=3)OC=2C(OC)=CC=C1\C=C\C1=CC=NC=C1 ILJUHJCUUOBOIN-BQYQJAHWSA-N 0.000 description 5
- AGGBKYHBUMELJH-UHFFFAOYSA-N 4-[2-(3,5-dichloropyridin-4-yl)acetyl]-7-methoxy-1-benzofuran-2-carbonitrile Chemical compound C1=2C=C(C#N)OC=2C(OC)=CC=C1C(=O)CC1=C(Cl)C=NC=C1Cl AGGBKYHBUMELJH-UHFFFAOYSA-N 0.000 description 5
- USCXANLCORAXJC-UHFFFAOYSA-N 4-bromo-1-methoxy-2-(3-methylidenepentan-2-yloxy)benzene Chemical compound CCC(=C)C(C)OC1=CC(Br)=CC=C1OC USCXANLCORAXJC-UHFFFAOYSA-N 0.000 description 5
- OLSJHVZRUFFIPL-UHFFFAOYSA-N 5-bromo-2-methoxyphenol Chemical compound COC1=CC=C(Br)C=C1O OLSJHVZRUFFIPL-UHFFFAOYSA-N 0.000 description 5
- AXMYIRRALJTEGA-UHFFFAOYSA-N 7-methoxy-2,3-dihydro-1-benzofuran-4-carboxylic acid Chemical compound COC1=CC=C(C(O)=O)C2=C1OCC2 AXMYIRRALJTEGA-UHFFFAOYSA-N 0.000 description 5
- ZUMQCOVTRGFXAU-UHFFFAOYSA-N 7-methoxy-2-pyridin-2-yl-1-benzofuran-4-carbaldehyde Chemical compound O1C=2C(OC)=CC=C(C=O)C=2C=C1C1=CC=CC=N1 ZUMQCOVTRGFXAU-UHFFFAOYSA-N 0.000 description 5
- GWABFHXXEJRKDR-UHFFFAOYSA-N 7-methoxyspiro[3h-1-benzofuran-2,1'-cyclohexane]-4-carbaldehyde Chemical compound O1C=2C(OC)=CC=C(C=O)C=2CC21CCCCC2 GWABFHXXEJRKDR-UHFFFAOYSA-N 0.000 description 5
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 5
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 5
- 235000019270 ammonium chloride Nutrition 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 5
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 5
- AKWRWNPPPLQCCS-UHFFFAOYSA-N n-(3,5-dichloropyridin-4-yl)-7-methoxy-3-propan-2-yl-2,3-dihydro-1-benzofuran-4-carboxamide Chemical compound C1=2C(C(C)C)COC=2C(OC)=CC=C1C(=O)NC1=C(Cl)C=NC=C1Cl AKWRWNPPPLQCCS-UHFFFAOYSA-N 0.000 description 5
- JJVNINGBHGBWJH-UHFFFAOYSA-N ortho-vanillin Chemical compound COC1=CC=CC(C=O)=C1O JJVNINGBHGBWJH-UHFFFAOYSA-N 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 239000012279 sodium borohydride Substances 0.000 description 5
- 229910000033 sodium borohydride Inorganic materials 0.000 description 5
- 239000012312 sodium hydride Substances 0.000 description 5
- 229910000104 sodium hydride Inorganic materials 0.000 description 5
- 210000003437 trachea Anatomy 0.000 description 5
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 4
- YJLIKUSWRSEPSM-WGQQHEPDSA-N (2r,3r,4s,5r)-2-[6-amino-8-[(4-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1CNC1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O YJLIKUSWRSEPSM-WGQQHEPDSA-N 0.000 description 4
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 4
- VGDRONPEFMZIIZ-UHFFFAOYSA-N 1-(2,2-diethyl-7-methoxy-3h-1-benzofuran-4-yl)-2-pyridin-4-ylethanol Chemical compound O1C(CC)(CC)CC2=C1C(OC)=CC=C2C(O)CC1=CC=NC=C1 VGDRONPEFMZIIZ-UHFFFAOYSA-N 0.000 description 4
- NYSJFGGDZCUFAY-UHFFFAOYSA-N 1-(2-benzoyl-7-methoxy-1-benzofuran-4-yl)-2-phenylethanone Chemical compound C1=2C=C(C(=O)C=3C=CC=CC=3)OC=2C(OC)=CC=C1C(=O)CC1=CC=CC=C1 NYSJFGGDZCUFAY-UHFFFAOYSA-N 0.000 description 4
- LUIWAQZIKWZIPV-UHFFFAOYSA-N 1-(2-butyl-7-methoxy-1-benzofuran-4-yl)-2-pyridin-4-ylethanone Chemical compound C1=CC(OC)=C2OC(CCCC)=CC2=C1C(=O)CC1=CC=NC=C1 LUIWAQZIKWZIPV-UHFFFAOYSA-N 0.000 description 4
- AMJHBYYKJVVDQS-UHFFFAOYSA-N 1-(7-methoxy-2,2-dimethyl-3h-1-benzofuran-4-yl)-2-pyridin-4-ylethanone Chemical compound C1=2CC(C)(C)OC=2C(OC)=CC=C1C(=O)CC1=CC=NC=C1 AMJHBYYKJVVDQS-UHFFFAOYSA-N 0.000 description 4
- CAMDGTMMMRXBMI-UHFFFAOYSA-N 1-(8-methoxyspiro[3,4-dihydrochromene-2,1'-cyclohexane]-5-yl)-2-pyridin-4-ylethanol Chemical compound C1=2CCC3(CCCCC3)OC=2C(OC)=CC=C1C(O)CC1=CC=NC=C1 CAMDGTMMMRXBMI-UHFFFAOYSA-N 0.000 description 4
- UNQFVMWZUFJHEO-UHFFFAOYSA-N 1-(8-methoxyspiro[3,4-dihydrochromene-2,1'-cyclopentane]-5-yl)-2-pyridin-4-ylethanol Chemical compound C1=2CCC3(CCCC3)OC=2C(OC)=CC=C1C(O)CC1=CC=NC=C1 UNQFVMWZUFJHEO-UHFFFAOYSA-N 0.000 description 4
- REOZLUDWDBYNBZ-UHFFFAOYSA-N 1-[2-(7-methoxy-1-benzofuran-2-yl)phenyl]ethanone Chemical compound O1C=2C(OC)=CC=CC=2C=C1C1=CC=CC=C1C(C)=O REOZLUDWDBYNBZ-UHFFFAOYSA-N 0.000 description 4
- UQDVNXFDDAIWAY-UHFFFAOYSA-N 2-(3,5-dichloropyridin-4-yl)-1-(7-methoxy-2-pyridin-2-yl-1-benzofuran-4-yl)ethanol Chemical compound C1=2C=C(C=3N=CC=CC=3)OC=2C(OC)=CC=C1C(O)CC1=C(Cl)C=NC=C1Cl UQDVNXFDDAIWAY-UHFFFAOYSA-N 0.000 description 4
- SXSMQJMUFRFDHK-UHFFFAOYSA-N 2-(3,5-dichloropyridin-4-yl)-1-(7-methoxy-2-pyridin-4-yl-1-benzofuran-4-yl)ethanol Chemical compound C1=2C=C(C=3C=CN=CC=3)OC=2C(OC)=CC=C1C(O)CC1=C(Cl)C=NC=C1Cl SXSMQJMUFRFDHK-UHFFFAOYSA-N 0.000 description 4
- WJXFFVMXLQJCFY-UHFFFAOYSA-N 2-(5-bromo-2-methoxyphenoxy)pentan-3-one Chemical compound CCC(=O)C(C)OC1=CC(Br)=CC=C1OC WJXFFVMXLQJCFY-UHFFFAOYSA-N 0.000 description 4
- KWEFRQUJRCRBJL-UHFFFAOYSA-N 2-(7-methoxy-2,2-dimethyl-3h-1-benzofuran-4-yl)-1-pyridin-4-ylpropan-2-ol Chemical compound C1=2CC(C)(C)OC=2C(OC)=CC=C1C(C)(O)CC1=CC=NC=C1 KWEFRQUJRCRBJL-UHFFFAOYSA-N 0.000 description 4
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 4
- WOBZETJGLJJASU-UHFFFAOYSA-N 2-bromo-3-cyclohex-2-en-1-yloxy-4-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C(Br)=C1OC1C=CCCC1 WOBZETJGLJJASU-UHFFFAOYSA-N 0.000 description 4
- QPDFBPIHEDAUKK-UHFFFAOYSA-N 2-bromo-3-hydroxy-4-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C(Br)=C1O QPDFBPIHEDAUKK-UHFFFAOYSA-N 0.000 description 4
- SCSOLNMTQAGFGV-UHFFFAOYSA-N 3-bromo-2-(cyclohex-2-en-1-ylmethyl)-6-methoxyphenol Chemical compound COC1=CC=C(Br)C(CC2C=CCCC2)=C1O SCSOLNMTQAGFGV-UHFFFAOYSA-N 0.000 description 4
- BPOGUTNDVZVPKE-UHFFFAOYSA-N 3-bromo-2-(cyclopent-2-en-1-ylmethyl)-4-methoxyphenol Chemical compound COC1=CC=C(O)C(CC2C=CCC2)=C1Br BPOGUTNDVZVPKE-UHFFFAOYSA-N 0.000 description 4
- GBADSQGMTBZRRM-UHFFFAOYSA-N 3-bromo-2-(cyclopent-2-en-1-ylmethyl)-6-methoxyphenol Chemical compound COC1=CC=C(Br)C(CC2C=CCC2)=C1O GBADSQGMTBZRRM-UHFFFAOYSA-N 0.000 description 4
- MRLFWJZKVMPQEP-UHFFFAOYSA-N 3-bromo-6-methoxy-2-(2-methylprop-2-enyl)phenol Chemical compound COC1=CC=C(Br)C(CC(C)=C)=C1O MRLFWJZKVMPQEP-UHFFFAOYSA-N 0.000 description 4
- GMYWTRKKTQIZIK-UHFFFAOYSA-N 3-ethyl-7-methoxy-2,3-dihydro-1-benzofuran-4-carboxylic acid Chemical compound OC(=O)C1=CC=C(OC)C2=C1C(CC)CO2 GMYWTRKKTQIZIK-UHFFFAOYSA-N 0.000 description 4
- DMPKDUSKVBEPOJ-UHFFFAOYSA-N 4-(7-methoxy-1-benzofuran-2-yl)pyridine Chemical compound O1C=2C(OC)=CC=CC=2C=C1C1=CC=NC=C1 DMPKDUSKVBEPOJ-UHFFFAOYSA-N 0.000 description 4
- ZDHKVKPZQKYREU-UHFFFAOYSA-N 4-(chloromethyl)pyridine;hydron;chloride Chemical compound Cl.ClCC1=CC=NC=C1 ZDHKVKPZQKYREU-UHFFFAOYSA-N 0.000 description 4
- SCAWTFZGERJGBB-ONEGZZNKSA-N 4-[(e)-2-(7-methoxy-3-methyl-2,3-dihydro-1-benzofuran-4-yl)ethenyl]pyridine Chemical compound C1=2C(C)COC=2C(OC)=CC=C1\C=C\C1=CC=NC=C1 SCAWTFZGERJGBB-ONEGZZNKSA-N 0.000 description 4
- IAGHCKJAPRYVHL-UHFFFAOYSA-N 4-[1,2-dibromo-2-(6-bromo-7-methoxyspiro[3h-1-benzofuran-2,1'-cyclopentane]-4-yl)ethyl]pyridine Chemical compound C1C2=C(C(Br)C(Br)C=3C=CN=CC=3)C=C(Br)C(OC)=C2OC21CCCC2 IAGHCKJAPRYVHL-UHFFFAOYSA-N 0.000 description 4
- NPABBUOBYSEMET-UHFFFAOYSA-N 4-[2-(6-bromo-7-methoxyspiro[3h-1-benzofuran-2,1'-cyclopentane]-4-yl)ethynyl]pyridine Chemical compound C1C2=C(C#CC=3C=CN=CC=3)C=C(Br)C(OC)=C2OC21CCCC2 NPABBUOBYSEMET-UHFFFAOYSA-N 0.000 description 4
- GBVXNVRMLBINDA-YRNVUSSQSA-N 4-[[(e)-3-(7-methoxyspiro[3h-1-benzofuran-2,1'-cyclopentane]-4-yl)prop-2-enoyl]amino]benzoic acid Chemical compound C1=2CC3(CCCC3)OC=2C(OC)=CC=C1\C=C\C(=O)NC1=CC=C(C(O)=O)C=C1 GBVXNVRMLBINDA-YRNVUSSQSA-N 0.000 description 4
- XFRREDIDDZMIRZ-UHFFFAOYSA-N 4-bromo-1-methoxy-2-(2-methylidenecyclopentyl)oxybenzene Chemical compound COC1=CC=C(Br)C=C1OC1C(=C)CCC1 XFRREDIDDZMIRZ-UHFFFAOYSA-N 0.000 description 4
- GDFLWOHRCFSHMM-UHFFFAOYSA-N 4-bromo-2,2-diethyl-7-methoxy-3h-1-benzofuran Chemical compound COC1=CC=C(Br)C2=C1OC(CC)(CC)C2 GDFLWOHRCFSHMM-UHFFFAOYSA-N 0.000 description 4
- XNJIPTPHGNNIQB-UHFFFAOYSA-N 7-methoxy-2-(2-methylpropyl)-1-benzofuran-4-carbaldehyde Chemical compound COC1=CC=C(C=O)C2=C1OC(CC(C)C)=C2 XNJIPTPHGNNIQB-UHFFFAOYSA-N 0.000 description 4
- UFTGDSBHVDZTDQ-UHFFFAOYSA-N 7-methoxy-2-(2-propan-2-ylphenyl)-1-benzofuran Chemical compound O1C=2C(OC)=CC=CC=2C=C1C1=CC=CC=C1C(C)C UFTGDSBHVDZTDQ-UHFFFAOYSA-N 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 241000700198 Cavia Species 0.000 description 4
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 4
- 125000004423 acyloxy group Chemical group 0.000 description 4
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 229940125898 compound 5 Drugs 0.000 description 4
- XJBQJXNFWWLWAT-VQHVLOKHSA-N ethyl (e)-3-(7-methoxyspiro[3h-1-benzofuran-2,1'-cyclopentane]-4-yl)prop-2-enoate Chemical compound C1C=2C(/C=C/C(=O)OCC)=CC=C(OC)C=2OC21CCCC2 XJBQJXNFWWLWAT-VQHVLOKHSA-N 0.000 description 4
- MUSCOFPISPUHCY-UHFFFAOYSA-N ethyl 2-[7-methoxy-4-(2-pyridin-4-ylacetyl)-1-benzofuran-3-yl]acetate Chemical compound C=12C(CC(=O)OCC)=COC2=C(OC)C=CC=1C(=O)CC1=CC=NC=C1 MUSCOFPISPUHCY-UHFFFAOYSA-N 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 239000005457 ice water Substances 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 4
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 4
- KJQXDMQIIDOIGD-UHFFFAOYSA-N methyl 4-methoxy-3-(3-methylidenepentan-2-yloxy)benzoate Chemical compound CCC(=C)C(C)OC1=CC(C(=O)OC)=CC=C1OC KJQXDMQIIDOIGD-UHFFFAOYSA-N 0.000 description 4
- NZYOFOUAVWYAMB-UHFFFAOYSA-N methyl 7-methoxy-1-benzofuran-4-carboxylate Chemical compound COC(=O)C1=CC=C(OC)C2=C1C=CO2 NZYOFOUAVWYAMB-UHFFFAOYSA-N 0.000 description 4
- SUCWHCVTNAPGEJ-UHFFFAOYSA-N methyl 7-methoxy-2,3-dihydro-1-benzofuran-4-carboxylate Chemical compound COC(=O)C1=CC=C(OC)C2=C1CCO2 SUCWHCVTNAPGEJ-UHFFFAOYSA-N 0.000 description 4
- QXXTVXHSIRBCKH-UHFFFAOYSA-N methyl 7-methoxy-2-(2-propan-2-ylphenyl)-1-benzofuran-4-carboxylate Chemical compound C=1C=2C(C(=O)OC)=CC=C(OC)C=2OC=1C1=CC=CC=C1C(C)C QXXTVXHSIRBCKH-UHFFFAOYSA-N 0.000 description 4
- ZBELDPMWYXDLNY-UHFFFAOYSA-N methyl 9-(4-bromo-2-fluoroanilino)-[1,3]thiazolo[5,4-f]quinazoline-2-carboximidate Chemical compound C12=C3SC(C(=N)OC)=NC3=CC=C2N=CN=C1NC1=CC=C(Br)C=C1F ZBELDPMWYXDLNY-UHFFFAOYSA-N 0.000 description 4
- 239000012046 mixed solvent Substances 0.000 description 4
- VOPGBWKHSHJYKN-UHFFFAOYSA-N n-(3,5-dichloropyridin-4-yl)-7-methoxyspiro[1,3-benzodioxole-2,1'-cyclopentane]-4-carboxamide Chemical compound C1=2OC3(CCCC3)OC=2C(OC)=CC=C1C(=O)NC1=C(Cl)C=NC=C1Cl VOPGBWKHSHJYKN-UHFFFAOYSA-N 0.000 description 4
- ZQGFFUGAMZEXKH-UHFFFAOYSA-N n-(3,5-dichloropyridin-4-yl)-8-methoxy-2,2-dimethylchromene-5-carboxamide Chemical compound C1=2C=CC(C)(C)OC=2C(OC)=CC=C1C(=O)NC1=C(Cl)C=NC=C1Cl ZQGFFUGAMZEXKH-UHFFFAOYSA-N 0.000 description 4
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 4
- 239000007800 oxidant agent Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 239000001119 stannous chloride Substances 0.000 description 4
- 235000011150 stannous chloride Nutrition 0.000 description 4
- 239000000829 suppository Substances 0.000 description 4
- 239000011592 zinc chloride Substances 0.000 description 4
- 235000005074 zinc chloride Nutrition 0.000 description 4
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 3
- GCTFTMWXZFLTRR-GFCCVEGCSA-N (2r)-2-amino-n-[3-(difluoromethoxy)-4-(1,3-oxazol-5-yl)phenyl]-4-methylpentanamide Chemical compound FC(F)OC1=CC(NC(=O)[C@H](N)CC(C)C)=CC=C1C1=CN=CO1 GCTFTMWXZFLTRR-GFCCVEGCSA-N 0.000 description 3
- VIJSPAIQWVPKQZ-BLECARSGSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoyl]amino]-4,4-dimethylpentanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O VIJSPAIQWVPKQZ-BLECARSGSA-N 0.000 description 3
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 3
- OOKAZRDERJMRCJ-KOUAFAAESA-N (3r)-7-[(1s,2s,4ar,6s,8s)-2,6-dimethyl-8-[(2s)-2-methylbutanoyl]oxy-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-3-hydroxy-5-oxoheptanoic acid Chemical compound C1=C[C@H](C)[C@H](CCC(=O)C[C@@H](O)CC(O)=O)C2[C@@H](OC(=O)[C@@H](C)CC)C[C@@H](C)C[C@@H]21 OOKAZRDERJMRCJ-KOUAFAAESA-N 0.000 description 3
- MPDDTAJMJCESGV-CTUHWIOQSA-M (3r,5r)-7-[2-(4-fluorophenyl)-5-[methyl-[(1r)-1-phenylethyl]carbamoyl]-4-propan-2-ylpyrazol-3-yl]-3,5-dihydroxyheptanoate Chemical compound C1([C@@H](C)N(C)C(=O)C2=NN(C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C2C(C)C)C=2C=CC(F)=CC=2)=CC=CC=C1 MPDDTAJMJCESGV-CTUHWIOQSA-M 0.000 description 3
- YQOLEILXOBUDMU-KRWDZBQOSA-N (4R)-5-[(6-bromo-3-methyl-2-pyrrolidin-1-ylquinoline-4-carbonyl)amino]-4-(2-chlorophenyl)pentanoic acid Chemical compound CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl YQOLEILXOBUDMU-KRWDZBQOSA-N 0.000 description 3
- VGQJIAYBZUFYSA-UHFFFAOYSA-N (7-methoxy-2,2-dimethyl-3h-1-benzofuran-4-yl)methanol Chemical compound COC1=CC=C(CO)C2=C1OC(C)(C)C2 VGQJIAYBZUFYSA-UHFFFAOYSA-N 0.000 description 3
- FXBXFFODQNGYRJ-UHFFFAOYSA-N 1-(7-methoxy-2-phenyl-1-benzofuran-4-yl)-2-pyridin-4-ylethanone Chemical compound C1=2C=C(C=3C=CC=CC=3)OC=2C(OC)=CC=C1C(=O)CC1=CC=NC=C1 FXBXFFODQNGYRJ-UHFFFAOYSA-N 0.000 description 3
- SSJQHPNMWHIKNN-UHFFFAOYSA-N 1-(7-methoxyspiro[1,3-benzodioxole-2,1'-cyclopentane]-4-yl)-1-phenyl-2-pyridin-4-ylethanol Chemical compound O1C=2C(OC)=CC=C(C(O)(CC=3C=CN=CC=3)C=3C=CC=CC=3)C=2OC21CCCC2 SSJQHPNMWHIKNN-UHFFFAOYSA-N 0.000 description 3
- ATRNQPJQSOFTRR-UHFFFAOYSA-N 1-(7-methoxyspiro[1,3-benzodioxole-2,1'-cyclopentane]-4-yl)-2-pyridin-4-ylethanone Chemical compound C1=2OC3(CCCC3)OC=2C(OC)=CC=C1C(=O)CC1=CC=NC=C1 ATRNQPJQSOFTRR-UHFFFAOYSA-N 0.000 description 3
- RJNSQRTVMMYAMU-UHFFFAOYSA-N 1-(7-methoxyspiro[3h-1-benzofuran-2,1'-cyclohexane]-4-yl)-2-pyridin-4-ylethanone;hydrochloride Chemical compound Cl.C1=2CC3(CCCCC3)OC=2C(OC)=CC=C1C(=O)CC1=CC=NC=C1 RJNSQRTVMMYAMU-UHFFFAOYSA-N 0.000 description 3
- GGYVTHJIUNGKFZ-UHFFFAOYSA-N 1-methylpiperidin-2-one Chemical compound CN1CCCCC1=O GGYVTHJIUNGKFZ-UHFFFAOYSA-N 0.000 description 3
- FQMZXMVHHKXGTM-UHFFFAOYSA-N 2-(1-adamantyl)-n-[2-[2-(2-hydroxyethylamino)ethylamino]quinolin-5-yl]acetamide Chemical compound C1C(C2)CC(C3)CC2CC13CC(=O)NC1=CC=CC2=NC(NCCNCCO)=CC=C21 FQMZXMVHHKXGTM-UHFFFAOYSA-N 0.000 description 3
- SGXXDRJIOWFRQR-UHFFFAOYSA-N 2-(2-ethenylphenyl)-7-methoxy-1-benzofuran Chemical compound O1C=2C(OC)=CC=CC=2C=C1C1=CC=CC=C1C=C SGXXDRJIOWFRQR-UHFFFAOYSA-N 0.000 description 3
- HJSQWXAJSFLDBG-UHFFFAOYSA-N 2-(2-ethylphenyl)-7-methoxy-1-benzofuran-4-carbaldehyde Chemical compound CCC1=CC=CC=C1C1=CC2=C(C=O)C=CC(OC)=C2O1 HJSQWXAJSFLDBG-UHFFFAOYSA-N 0.000 description 3
- CUTDYHICKWDPMY-UHFFFAOYSA-N 2-(7-methoxy-1-benzofuran-2-yl)pyridine Chemical compound O1C=2C(OC)=CC=CC=2C=C1C1=CC=CC=N1 CUTDYHICKWDPMY-UHFFFAOYSA-N 0.000 description 3
- FMKGJQHNYMWDFJ-CVEARBPZSA-N 2-[[4-(2,2-difluoropropoxy)pyrimidin-5-yl]methylamino]-4-[[(1R,4S)-4-hydroxy-3,3-dimethylcyclohexyl]amino]pyrimidine-5-carbonitrile Chemical compound FC(COC1=NC=NC=C1CNC1=NC=C(C(=N1)N[C@H]1CC([C@H](CC1)O)(C)C)C#N)(C)F FMKGJQHNYMWDFJ-CVEARBPZSA-N 0.000 description 3
- VVCMGAUPZIKYTH-VGHSCWAPSA-N 2-acetyloxybenzoic acid;[(2s,3r)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate;1,3,7-trimethylpurine-2,6-dione Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O.CN1C(=O)N(C)C(=O)C2=C1N=CN2C.C([C@](OC(=O)CC)([C@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 VVCMGAUPZIKYTH-VGHSCWAPSA-N 0.000 description 3
- LFOIDLOIBZFWDO-UHFFFAOYSA-N 2-methoxy-6-[6-methoxy-4-[(3-phenylmethoxyphenyl)methoxy]-1-benzofuran-2-yl]imidazo[2,1-b][1,3,4]thiadiazole Chemical compound N1=C2SC(OC)=NN2C=C1C(OC1=CC(OC)=C2)=CC1=C2OCC(C=1)=CC=CC=1OCC1=CC=CC=C1 LFOIDLOIBZFWDO-UHFFFAOYSA-N 0.000 description 3
- YBHYECGRNFZJPC-UHFFFAOYSA-N 3,5-dichloro-4-methylpyridine Chemical compound CC1=C(Cl)C=NC=C1Cl YBHYECGRNFZJPC-UHFFFAOYSA-N 0.000 description 3
- DFRAKBCRUYUFNT-UHFFFAOYSA-N 3,8-dicyclohexyl-2,4,7,9-tetrahydro-[1,3]oxazino[5,6-h][1,3]benzoxazine Chemical compound C1CCCCC1N1CC(C=CC2=C3OCN(C2)C2CCCCC2)=C3OC1 DFRAKBCRUYUFNT-UHFFFAOYSA-N 0.000 description 3
- LVUXCAIOYHZWDO-UHFFFAOYSA-N 3-bromo-2-(2-ethylbut-2-enyl)-6-methoxyphenol Chemical compound CCC(=CC)CC1=C(Br)C=CC(OC)=C1O LVUXCAIOYHZWDO-UHFFFAOYSA-N 0.000 description 3
- WYFCZWSWFGJODV-MIANJLSGSA-N 4-[[(1s)-2-[(e)-3-[3-chloro-2-fluoro-6-(tetrazol-1-yl)phenyl]prop-2-enoyl]-5-(4-methyl-2-oxopiperazin-1-yl)-3,4-dihydro-1h-isoquinoline-1-carbonyl]amino]benzoic acid Chemical compound O=C1CN(C)CCN1C1=CC=CC2=C1CCN(C(=O)\C=C\C=1C(=CC=C(Cl)C=1F)N1N=NN=C1)[C@@H]2C(=O)NC1=CC=C(C(O)=O)C=C1 WYFCZWSWFGJODV-MIANJLSGSA-N 0.000 description 3
- XYSYKOFMYLWSKX-UHFFFAOYSA-N 4-bromo-7-methoxy-2,2-dimethyl-3h-1-benzofuran Chemical compound COC1=CC=C(Br)C2=C1OC(C)(C)C2 XYSYKOFMYLWSKX-UHFFFAOYSA-N 0.000 description 3
- GSDQYSSLIKJJOG-UHFFFAOYSA-N 4-chloro-2-(3-chloroanilino)benzoic acid Chemical compound OC(=O)C1=CC=C(Cl)C=C1NC1=CC=CC(Cl)=C1 GSDQYSSLIKJJOG-UHFFFAOYSA-N 0.000 description 3
- GHMNFIKTKSFDMQ-UHFFFAOYSA-N 4-formyl-7-methoxy-1-benzofuran-2-carbonitrile Chemical compound COC1=CC=C(C=O)C2=C1OC(C#N)=C2 GHMNFIKTKSFDMQ-UHFFFAOYSA-N 0.000 description 3
- GDUANFXPOZTYKS-UHFFFAOYSA-N 6-bromo-8-[(2,6-difluoro-4-methoxybenzoyl)amino]-4-oxochromene-2-carboxylic acid Chemical compound FC1=CC(OC)=CC(F)=C1C(=O)NC1=CC(Br)=CC2=C1OC(C(O)=O)=CC2=O GDUANFXPOZTYKS-UHFFFAOYSA-N 0.000 description 3
- JLLFJAINNHDTJT-UHFFFAOYSA-N 7-methoxy-2,2-dimethyl-3h-1-benzofuran-4-carbaldehyde Chemical compound COC1=CC=C(C=O)C2=C1OC(C)(C)C2 JLLFJAINNHDTJT-UHFFFAOYSA-N 0.000 description 3
- BEAVLXUJCFRGGL-UHFFFAOYSA-N 7-methoxy-2-(2-methylpropyl)-1-benzofuran Chemical compound COC1=CC=CC2=C1OC(CC(C)C)=C2 BEAVLXUJCFRGGL-UHFFFAOYSA-N 0.000 description 3
- KLBLAJPILOMZFR-UHFFFAOYSA-N 7-methoxy-2-(4-nitrophenyl)-1-benzofuran Chemical compound O1C=2C(OC)=CC=CC=2C=C1C1=CC=C([N+]([O-])=O)C=C1 KLBLAJPILOMZFR-UHFFFAOYSA-N 0.000 description 3
- AUJSDWKSNXVGQX-UHFFFAOYSA-N 7-methoxy-2-phenyl-1-benzofuran Chemical compound O1C=2C(OC)=CC=CC=2C=C1C1=CC=CC=C1 AUJSDWKSNXVGQX-UHFFFAOYSA-N 0.000 description 3
- MLLUEKSLVITXGB-UHFFFAOYSA-N 7-methoxy-2-phenyl-1-benzofuran-4-carbaldehyde Chemical compound O1C=2C(OC)=CC=C(C=O)C=2C=C1C1=CC=CC=C1 MLLUEKSLVITXGB-UHFFFAOYSA-N 0.000 description 3
- GEICOJLXTJAUSM-UHFFFAOYSA-N 7-methoxy-n-pyridin-4-ylspiro[1,3-benzodioxole-2,1'-cyclopentane]-4-carboxamide Chemical compound C1=2OC3(CCCC3)OC=2C(OC)=CC=C1C(=O)NC1=CC=NC=C1 GEICOJLXTJAUSM-UHFFFAOYSA-N 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 241001631457 Cannula Species 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 3
- PSLUFJFHTBIXMW-WYEYVKMPSA-N [(3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-6-(2-pyridin-2-ylethylcarbamoyloxy)-5,6,6a,8,9,10-hexahydro-2h-benzo[f]chromen-5-yl] acetate Chemical compound O([C@@H]1[C@@H]([C@]2(O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@@H]21)C=C)C)OC(=O)C)C(=O)NCCC1=CC=CC=N1 PSLUFJFHTBIXMW-WYEYVKMPSA-N 0.000 description 3
- SMNRFWMNPDABKZ-WVALLCKVSA-N [[(2R,3S,4R,5S)-5-(2,6-dioxo-3H-pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4S,5R,6R)-4-fluoro-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)C2C=CC(=O)NC2=O)[C@H](O)[C@@H](F)[C@@H]1O SMNRFWMNPDABKZ-WVALLCKVSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 229940125773 compound 10 Drugs 0.000 description 3
- 229940125797 compound 12 Drugs 0.000 description 3
- 229940126086 compound 21 Drugs 0.000 description 3
- 229940125844 compound 46 Drugs 0.000 description 3
- 229940126545 compound 53 Drugs 0.000 description 3
- 229940127113 compound 57 Drugs 0.000 description 3
- 229940125900 compound 59 Drugs 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 150000001907 coumarones Chemical class 0.000 description 3
- QVQGTNFYPJQJNM-UHFFFAOYSA-N dicyclohexylmethanamine Chemical compound C1CCCCC1C(N)C1CCCCC1 QVQGTNFYPJQJNM-UHFFFAOYSA-N 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- MVEAAGBEUOMFRX-UHFFFAOYSA-N ethyl acetate;hydrochloride Chemical compound Cl.CCOC(C)=O MVEAAGBEUOMFRX-UHFFFAOYSA-N 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 3
- 229960000443 hydrochloric acid Drugs 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 235000011147 magnesium chloride Nutrition 0.000 description 3
- NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 3
- PGNZZGIPLJFOBJ-UHFFFAOYSA-N methyl 4-methoxy-3-(2-methylidenecyclohexyl)oxybenzoate Chemical compound COC(=O)C1=CC=C(OC)C(OC2C(CCCC2)=C)=C1 PGNZZGIPLJFOBJ-UHFFFAOYSA-N 0.000 description 3
- VDFNXLLBUAIJSS-UHFFFAOYSA-N methyl 4-methoxy-3-(2-oxocyclohexyl)oxybenzoate Chemical compound COC(=O)C1=CC=C(OC)C(OC2C(CCCC2)=O)=C1 VDFNXLLBUAIJSS-UHFFFAOYSA-N 0.000 description 3
- XXZVIECAQOYQGN-UHFFFAOYSA-N methyl 7-methoxy-2-pyridin-2-yl-1-benzofuran-4-carboxylate Chemical compound C=1C=2C(C(=O)OC)=CC=C(OC)C=2OC=1C1=CC=CC=N1 XXZVIECAQOYQGN-UHFFFAOYSA-N 0.000 description 3
- 201000006417 multiple sclerosis Diseases 0.000 description 3
- YCJZWBZJSYLMPB-UHFFFAOYSA-N n-(2-chloropyrimidin-4-yl)-2,5-dimethyl-1-phenylimidazole-4-carboxamide Chemical compound CC=1N(C=2C=CC=CC=2)C(C)=NC=1C(=O)NC1=CC=NC(Cl)=N1 YCJZWBZJSYLMPB-UHFFFAOYSA-N 0.000 description 3
- CNCGRQYQCYCVMR-UHFFFAOYSA-N n-(3,5-dichloropyridin-4-yl)-4-methoxyspiro[3h-1-benzofuran-2,1'-cyclopentane]-7-carboxamide Chemical compound C1=2OC3(CCCC3)CC=2C(OC)=CC=C1C(=O)NC1=C(Cl)C=NC=C1Cl CNCGRQYQCYCVMR-UHFFFAOYSA-N 0.000 description 3
- YGBMCLDVRUGXOV-UHFFFAOYSA-N n-[6-[6-chloro-5-[(4-fluorophenyl)sulfonylamino]pyridin-3-yl]-1,3-benzothiazol-2-yl]acetamide Chemical compound C1=C2SC(NC(=O)C)=NC2=CC=C1C(C=1)=CN=C(Cl)C=1NS(=O)(=O)C1=CC=C(F)C=C1 YGBMCLDVRUGXOV-UHFFFAOYSA-N 0.000 description 3
- IOMMMLWIABWRKL-WUTDNEBXSA-N nazartinib Chemical compound C1N(C(=O)/C=C/CN(C)C)CCCC[C@H]1N1C2=C(Cl)C=CC=C2N=C1NC(=O)C1=CC=NC(C)=C1 IOMMMLWIABWRKL-WUTDNEBXSA-N 0.000 description 3
- 229940092253 ovalbumin Drugs 0.000 description 3
- ANRQGKOBLBYXFM-UHFFFAOYSA-M phenylmagnesium bromide Chemical compound Br[Mg]C1=CC=CC=C1 ANRQGKOBLBYXFM-UHFFFAOYSA-M 0.000 description 3
- 239000002587 phosphodiesterase IV inhibitor Substances 0.000 description 3
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 3
- 229910000105 potassium hydride Inorganic materials 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 125000006239 protecting group Chemical group 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 230000000241 respiratory effect Effects 0.000 description 3
- 206010039073 rheumatoid arthritis Diseases 0.000 description 3
- 210000002460 smooth muscle Anatomy 0.000 description 3
- 229940032330 sulfuric acid Drugs 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 3
- ASGMFNBUXDJWJJ-JLCFBVMHSA-N (1R,3R)-3-[[3-bromo-1-[4-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]-N,1-dimethylcyclopentane-1-carboxamide Chemical compound BrC1=NN(C2=NC(=NC=C21)N[C@H]1C[C@@](CC1)(C(=O)NC)C)C1=CC=C(C=C1)C=1SC(=NN=1)C ASGMFNBUXDJWJJ-JLCFBVMHSA-N 0.000 description 2
- UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 description 2
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 2
- ABJSOROVZZKJGI-OCYUSGCXSA-N (1r,2r,4r)-2-(4-bromophenyl)-n-[(4-chlorophenyl)-(2-fluoropyridin-4-yl)methyl]-4-morpholin-4-ylcyclohexane-1-carboxamide Chemical compound C1=NC(F)=CC(C(NC(=O)[C@H]2[C@@H](C[C@@H](CC2)N2CCOCC2)C=2C=CC(Br)=CC=2)C=2C=CC(Cl)=CC=2)=C1 ABJSOROVZZKJGI-OCYUSGCXSA-N 0.000 description 2
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 2
- IUSARDYWEPUTPN-OZBXUNDUSA-N (2r)-n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-[3-(1,3-thiazol-2-yl)phenyl]butan-2-yl]-2-methoxypropanamide Chemical compound C([C@H](NC(=O)[C@@H](C)OC)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C(C=1)=CC=CC=1C1=NC=CS1 IUSARDYWEPUTPN-OZBXUNDUSA-N 0.000 description 2
- WWTBZEKOSBFBEM-SPWPXUSOSA-N (2s)-2-[[2-benzyl-3-[hydroxy-[(1r)-2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphoryl]propanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)C(CP(O)(=O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1C=CC=CC=1)CC1=CC=CC=C1 WWTBZEKOSBFBEM-SPWPXUSOSA-N 0.000 description 2
- STBLNCCBQMHSRC-BATDWUPUSA-N (2s)-n-[(3s,4s)-5-acetyl-7-cyano-4-methyl-1-[(2-methylnaphthalen-1-yl)methyl]-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide Chemical compound O=C1[C@@H](NC(=O)[C@H](C)NC)[C@H](C)N(C(C)=O)C2=CC(C#N)=CC=C2N1CC1=C(C)C=CC2=CC=CC=C12 STBLNCCBQMHSRC-BATDWUPUSA-N 0.000 description 2
- FNHHVPPSBFQMEL-KQHDFZBMSA-N (3S)-5-N-[(1S,5R)-3-hydroxy-6-bicyclo[3.1.0]hexanyl]-7-N,3-dimethyl-3-phenyl-2H-1-benzofuran-5,7-dicarboxamide Chemical compound CNC(=O)c1cc(cc2c1OC[C@@]2(C)c1ccccc1)C(=O)NC1[C@H]2CC(O)C[C@@H]12 FNHHVPPSBFQMEL-KQHDFZBMSA-N 0.000 description 2
- UDQTXCHQKHIQMH-KYGLGHNPSA-N (3ar,5s,6s,7r,7ar)-5-(difluoromethyl)-2-(ethylamino)-5,6,7,7a-tetrahydro-3ah-pyrano[3,2-d][1,3]thiazole-6,7-diol Chemical compound S1C(NCC)=N[C@H]2[C@@H]1O[C@H](C(F)F)[C@@H](O)[C@@H]2O UDQTXCHQKHIQMH-KYGLGHNPSA-N 0.000 description 2
- HUWSZNZAROKDRZ-RRLWZMAJSA-N (3r,4r)-3-azaniumyl-5-[[(2s,3r)-1-[(2s)-2,3-dicarboxypyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-5-oxo-4-sulfanylpentane-1-sulfonate Chemical compound OS(=O)(=O)CC[C@@H](N)[C@@H](S)C(=O)N[C@@H]([C@H](C)CC)C(=O)N1CCC(C(O)=O)[C@H]1C(O)=O HUWSZNZAROKDRZ-RRLWZMAJSA-N 0.000 description 2
- STPKWKPURVSAJF-LJEWAXOPSA-N (4r,5r)-5-[4-[[4-(1-aza-4-azoniabicyclo[2.2.2]octan-4-ylmethyl)phenyl]methoxy]phenyl]-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2h-1$l^{6}-benzothiepin-4-ol Chemical compound O[C@H]1C(CCCC)(CCCC)CS(=O)(=O)C2=CC=C(N(C)C)C=C2[C@H]1C(C=C1)=CC=C1OCC(C=C1)=CC=C1C[N+]1(CC2)CCN2CC1 STPKWKPURVSAJF-LJEWAXOPSA-N 0.000 description 2
- DEVSOMFAQLZNKR-RJRFIUFISA-N (z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-n'-pyrazin-2-ylprop-2-enehydrazide Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(C2=NN(\C=C/C(=O)NNC=3N=CC=NC=3)C=N2)=C1 DEVSOMFAQLZNKR-RJRFIUFISA-N 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- UWYZHKAOTLEWKK-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC=C2CNCCC2=C1 UWYZHKAOTLEWKK-UHFFFAOYSA-N 0.000 description 2
- DJMOXMNDXFFONV-UHFFFAOYSA-N 1,3-dimethyl-7-[2-(n-methylanilino)ethyl]purine-2,6-dione Chemical compound C1=NC=2N(C)C(=O)N(C)C(=O)C=2N1CCN(C)C1=CC=CC=C1 DJMOXMNDXFFONV-UHFFFAOYSA-N 0.000 description 2
- KKHFRAFPESRGGD-UHFFFAOYSA-N 1,3-dimethyl-7-[3-(n-methylanilino)propyl]purine-2,6-dione Chemical compound C1=NC=2N(C)C(=O)N(C)C(=O)C=2N1CCCN(C)C1=CC=CC=C1 KKHFRAFPESRGGD-UHFFFAOYSA-N 0.000 description 2
- JXHWNYBTUYZQMT-UHFFFAOYSA-N 1-(2,2-diethyl-7-methoxy-3h-1-benzofuran-4-yl)-2-pyridin-4-ylethanone Chemical compound O1C(CC)(CC)CC2=C1C(OC)=CC=C2C(=O)CC1=CC=NC=C1 JXHWNYBTUYZQMT-UHFFFAOYSA-N 0.000 description 2
- LWJBGPXFDWWBHF-UHFFFAOYSA-N 1-(2-benzoyl-7-methoxy-1-benzofuran-4-yl)-2-pyridin-4-ylethanone Chemical compound C1=2C=C(C(=O)C=3C=CC=CC=3)OC=2C(OC)=CC=C1C(=O)CC1=CC=NC=C1 LWJBGPXFDWWBHF-UHFFFAOYSA-N 0.000 description 2
- HUHMEBLSRXDQHU-UHFFFAOYSA-N 1-(7-methoxy-2-pyridin-4-yl-1-benzofuran-4-yl)-2-pyridin-4-ylethanone Chemical compound C1=2C=C(C=3C=CN=CC=3)OC=2C(OC)=CC=C1C(=O)CC1=CC=NC=C1 HUHMEBLSRXDQHU-UHFFFAOYSA-N 0.000 description 2
- KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 description 2
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 description 2
- AHVXQCFSGWRGRL-UHFFFAOYSA-N 1-[2-(2-ethylphenyl)-7-methoxy-1-benzofuran-4-yl]-2-pyridin-4-ylethanone Chemical compound CCC1=CC=CC=C1C1=CC2=C(C(=O)CC=3C=CN=CC=3)C=CC(OC)=C2O1 AHVXQCFSGWRGRL-UHFFFAOYSA-N 0.000 description 2
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 2
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 2
- FHTDDANQIMVWKZ-UHFFFAOYSA-N 1h-pyridine-4-thione Chemical compound SC1=CC=NC=C1 FHTDDANQIMVWKZ-UHFFFAOYSA-N 0.000 description 2
- ZDXMAPDREQADEW-UHFFFAOYSA-N 2,2-diethyl-7-methoxy-3h-1-benzofuran-4-carbaldehyde Chemical compound COC1=CC=C(C=O)C2=C1OC(CC)(CC)C2 ZDXMAPDREQADEW-UHFFFAOYSA-N 0.000 description 2
- VCUXVXLUOHDHKK-UHFFFAOYSA-N 2-(2-aminopyrimidin-4-yl)-4-(2-chloro-4-methoxyphenyl)-1,3-thiazole-5-carboxamide Chemical compound ClC1=CC(OC)=CC=C1C1=C(C(N)=O)SC(C=2N=C(N)N=CC=2)=N1 VCUXVXLUOHDHKK-UHFFFAOYSA-N 0.000 description 2
- QEBYEVQKHRUYPE-UHFFFAOYSA-N 2-(2-chlorophenyl)-5-[(1-methylpyrazol-3-yl)methyl]-4-[[methyl(pyridin-3-ylmethyl)amino]methyl]-1h-pyrazolo[4,3-c]pyridine-3,6-dione Chemical compound C1=CN(C)N=C1CN1C(=O)C=C2NN(C=3C(=CC=CC=3)Cl)C(=O)C2=C1CN(C)CC1=CC=CN=C1 QEBYEVQKHRUYPE-UHFFFAOYSA-N 0.000 description 2
- STQZWMAXSHABSS-UHFFFAOYSA-N 2-(3,5-dichloropyridin-4-yl)-1-(7-methoxy-2-pyridin-2-yl-1-benzofuran-4-yl)ethanone Chemical compound C1=2C=C(C=3N=CC=CC=3)OC=2C(OC)=CC=C1C(=O)CC1=C(Cl)C=NC=C1Cl STQZWMAXSHABSS-UHFFFAOYSA-N 0.000 description 2
- ARWUKCANBFQEBG-UHFFFAOYSA-N 2-(3,5-dichloropyridin-4-yl)-1-(7-methoxy-2-pyridin-4-yl-1-benzofuran-4-yl)ethanone Chemical compound C1=2C=C(C=3C=CN=CC=3)OC=2C(OC)=CC=C1C(=O)CC1=C(Cl)C=NC=C1Cl ARWUKCANBFQEBG-UHFFFAOYSA-N 0.000 description 2
- XHLMDDJBDGEDSA-UHFFFAOYSA-N 2-(7-methoxy-1-benzofuran-2-yl)benzonitrile Chemical compound O1C=2C(OC)=CC=CC=2C=C1C1=CC=CC=C1C#N XHLMDDJBDGEDSA-UHFFFAOYSA-N 0.000 description 2
- PYRKKGOKRMZEIT-UHFFFAOYSA-N 2-[6-(2-cyclopropylethoxy)-9-(2-hydroxy-2-methylpropyl)-1h-phenanthro[9,10-d]imidazol-2-yl]-5-fluorobenzene-1,3-dicarbonitrile Chemical compound C1=C2C3=CC(CC(C)(O)C)=CC=C3C=3NC(C=4C(=CC(F)=CC=4C#N)C#N)=NC=3C2=CC=C1OCCC1CC1 PYRKKGOKRMZEIT-UHFFFAOYSA-N 0.000 description 2
- PTWATGXXZAABEF-AATRIKPKSA-N 2-[7-methoxy-4-[(e)-2-pyridin-4-ylethenyl]-1-benzofuran-2-yl]pyridine Chemical compound C1=2C=C(C=3N=CC=CC=3)OC=2C(OC)=CC=C1\C=C\C1=CC=NC=C1 PTWATGXXZAABEF-AATRIKPKSA-N 0.000 description 2
- PAYROHWFGZADBR-UHFFFAOYSA-N 2-[[4-amino-5-(5-iodo-4-methoxy-2-propan-2-ylphenoxy)pyrimidin-2-yl]amino]propane-1,3-diol Chemical compound C1=C(I)C(OC)=CC(C(C)C)=C1OC1=CN=C(NC(CO)CO)N=C1N PAYROHWFGZADBR-UHFFFAOYSA-N 0.000 description 2
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 description 2
- TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 description 2
- NPRYCHLHHVWLQZ-TURQNECASA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynylpurin-8-one Chemical compound NC1=NC=C2N(C(N(C2=N1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C NPRYCHLHHVWLQZ-TURQNECASA-N 0.000 description 2
- OVYLRLZSQDNGCJ-UHFFFAOYSA-N 2-benzyl-7-methoxy-1-benzofuran-4-carboxylic acid Chemical compound O1C=2C(OC)=CC=C(C(O)=O)C=2C=C1CC1=CC=CC=C1 OVYLRLZSQDNGCJ-UHFFFAOYSA-N 0.000 description 2
- VUDTYIUNUSPULX-UHFFFAOYSA-N 2-bromopentan-3-one Chemical compound CCC(=O)C(C)Br VUDTYIUNUSPULX-UHFFFAOYSA-N 0.000 description 2
- JXPDNDHCMMOJPC-UHFFFAOYSA-N 2-hydroxybutanedinitrile Chemical compound N#CC(O)CC#N JXPDNDHCMMOJPC-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- BMVSAKPRNWZCPG-UHFFFAOYSA-N 2-pyridin-4-ylacetonitrile Chemical compound N#CCC1=CC=NC=C1 BMVSAKPRNWZCPG-UHFFFAOYSA-N 0.000 description 2
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 description 2
- LGSLAGIVZYAJCR-SOFGYWHQSA-N 3,5-dichloro-4-[(e)-2-(2,2-diethyl-7-methoxy-3h-1-benzofuran-4-yl)ethenyl]pyridine Chemical compound O1C(CC)(CC)CC2=C1C(OC)=CC=C2\C=C\C1=C(Cl)C=NC=C1Cl LGSLAGIVZYAJCR-SOFGYWHQSA-N 0.000 description 2
- QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 description 2
- WFOVEDJTASPCIR-UHFFFAOYSA-N 3-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)methylamino]-n-[[2-(trifluoromethyl)phenyl]methyl]benzamide Chemical compound N=1N=C(C=2C=CN=CC=2)N(C)C=1CNC(C=1)=CC=CC=1C(=O)NCC1=CC=CC=C1C(F)(F)F WFOVEDJTASPCIR-UHFFFAOYSA-N 0.000 description 2
- CUYKNJBYIJFRCU-UHFFFAOYSA-N 3-aminopyridine Chemical compound NC1=CC=CN=C1 CUYKNJBYIJFRCU-UHFFFAOYSA-N 0.000 description 2
- QSILYWCNPOLKPN-UHFFFAOYSA-N 3-chloro-3-methylbut-1-yne Chemical compound CC(C)(Cl)C#C QSILYWCNPOLKPN-UHFFFAOYSA-N 0.000 description 2
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 2
- LPYUENQFPVNPHY-UHFFFAOYSA-N 3-methoxycatechol Chemical compound COC1=CC=CC(O)=C1O LPYUENQFPVNPHY-UHFFFAOYSA-N 0.000 description 2
- MPMKMQHJHDHPBE-RUZDIDTESA-N 4-[[(2r)-1-(1-benzothiophene-3-carbonyl)-2-methylazetidine-2-carbonyl]-[(3-chlorophenyl)methyl]amino]butanoic acid Chemical compound O=C([C@@]1(N(CC1)C(=O)C=1C2=CC=CC=C2SC=1)C)N(CCCC(O)=O)CC1=CC=CC(Cl)=C1 MPMKMQHJHDHPBE-RUZDIDTESA-N 0.000 description 2
- NUKYPUAOHBNCPY-UHFFFAOYSA-N 4-aminopyridine Chemical compound NC1=CC=NC=C1 NUKYPUAOHBNCPY-UHFFFAOYSA-N 0.000 description 2
- LSFPMOBPXXDQRL-UHFFFAOYSA-N 4-bromo-1-methoxy-2-(2-methylidenecyclohexyl)oxybenzene Chemical compound COC1=CC=C(Br)C=C1OC1C(=C)CCCC1 LSFPMOBPXXDQRL-UHFFFAOYSA-N 0.000 description 2
- GONRASPMOGEKBI-UHFFFAOYSA-N 4-bromo-1-methoxy-2-(2-methylprop-2-enoxy)benzene Chemical compound COC1=CC=C(Br)C=C1OCC(C)=C GONRASPMOGEKBI-UHFFFAOYSA-N 0.000 description 2
- QQZPSILVRXNOQJ-UHFFFAOYSA-N 4-methoxyspiro[3h-1-benzofuran-2,1'-cyclopentane]-7-carbaldehyde Chemical compound C1C=2C(OC)=CC=C(C=O)C=2OC21CCCC2 QQZPSILVRXNOQJ-UHFFFAOYSA-N 0.000 description 2
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- VKLKXFOZNHEBSW-UHFFFAOYSA-N 5-[[3-[(4-morpholin-4-ylbenzoyl)amino]phenyl]methoxy]pyridine-3-carboxamide Chemical compound O1CCN(CC1)C1=CC=C(C(=O)NC=2C=C(COC=3C=NC=C(C(=O)N)C=3)C=CC=2)C=C1 VKLKXFOZNHEBSW-UHFFFAOYSA-N 0.000 description 2
- XFJBGINZIMNZBW-CRAIPNDOSA-N 5-chloro-2-[4-[(1r,2s)-2-[2-(5-methylsulfonylpyridin-2-yl)oxyethyl]cyclopropyl]piperidin-1-yl]pyrimidine Chemical compound N1=CC(S(=O)(=O)C)=CC=C1OCC[C@H]1[C@@H](C2CCN(CC2)C=2N=CC(Cl)=CN=2)C1 XFJBGINZIMNZBW-CRAIPNDOSA-N 0.000 description 2
- IJRKLHTZAIFUTB-UHFFFAOYSA-N 5-nitro-2-(2-phenylethylamino)benzoic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC=C1NCCC1=CC=CC=C1 IJRKLHTZAIFUTB-UHFFFAOYSA-N 0.000 description 2
- RSIWALKZYXPAGW-NSHDSACASA-N 6-(3-fluorophenyl)-3-methyl-7-[(1s)-1-(7h-purin-6-ylamino)ethyl]-[1,3]thiazolo[3,2-a]pyrimidin-5-one Chemical compound C=1([C@@H](NC=2C=3N=CNC=3N=CN=2)C)N=C2SC=C(C)N2C(=O)C=1C1=CC=CC(F)=C1 RSIWALKZYXPAGW-NSHDSACASA-N 0.000 description 2
- IRBYXKAZUXVYEX-UHFFFAOYSA-N 7-methoxy-1-benzofuran-2-carbonitrile Chemical compound COC1=CC=CC2=C1OC(C#N)=C2 IRBYXKAZUXVYEX-UHFFFAOYSA-N 0.000 description 2
- WJWFXQQKZBYTMN-UHFFFAOYSA-N 7-methoxy-1-benzofuran-4-carboxylic acid Chemical compound COC1=CC=C(C(O)=O)C2=C1OC=C2 WJWFXQQKZBYTMN-UHFFFAOYSA-N 0.000 description 2
- ZADRSTZPCAHKPY-UHFFFAOYSA-N 7-methoxy-2-(2-methylprop-1-enyl)-1-benzofuran Chemical compound COC1=CC=CC2=C1OC(C=C(C)C)=C2 ZADRSTZPCAHKPY-UHFFFAOYSA-N 0.000 description 2
- HPJKJXGGEKEJMR-UHFFFAOYSA-N 7-methoxy-2-(2-propan-2-ylphenyl)-1-benzofuran-4-carbaldehyde Chemical compound O1C=2C(OC)=CC=C(C=O)C=2C=C1C1=CC=CC=C1C(C)C HPJKJXGGEKEJMR-UHFFFAOYSA-N 0.000 description 2
- KVZKILUZWAAHGV-UHFFFAOYSA-N 7-methoxy-2-pyridin-2-yl-n-pyridin-4-yl-1-benzofuran-4-carboxamide Chemical compound C1=2C=C(C=3N=CC=CC=3)OC=2C(OC)=CC=C1C(=O)NC1=CC=NC=C1 KVZKILUZWAAHGV-UHFFFAOYSA-N 0.000 description 2
- XASOHFCUIQARJT-UHFFFAOYSA-N 8-methoxy-6-[7-(2-morpholin-4-ylethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one Chemical compound C(N1C(=O)C2=C(OC)C=C(C=3N4C(=NC=3)C=C(C=C4)OCCN3CCOCC3)C=C2CC1)C(F)(F)F XASOHFCUIQARJT-UHFFFAOYSA-N 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- JQUCWIWWWKZNCS-LESHARBVSA-N C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F Chemical compound C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F JQUCWIWWWKZNCS-LESHARBVSA-N 0.000 description 2
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 2
- OJRUSAPKCPIVBY-KQYNXXCUSA-N C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(CP(=O)(O)O)O)O)O)I)N Chemical compound C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(CP(=O)(O)O)O)O)O)I)N OJRUSAPKCPIVBY-KQYNXXCUSA-N 0.000 description 2
- KCBAMQOKOLXLOX-BSZYMOERSA-N CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCCCCCNCCCONC(=O)C4=C(C(=C(C=C4)F)F)NC5=C(C=C(C=C5)I)F)O Chemical compound CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCCCCCNCCCONC(=O)C4=C(C(=C(C=C4)F)F)NC5=C(C=C(C=C5)I)F)O KCBAMQOKOLXLOX-BSZYMOERSA-N 0.000 description 2
- PKMUHQIDVVOXHQ-HXUWFJFHSA-N C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O Chemical compound C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O PKMUHQIDVVOXHQ-HXUWFJFHSA-N 0.000 description 2
- 102000016289 Cell Adhesion Molecules Human genes 0.000 description 2
- 108010067225 Cell Adhesion Molecules Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 229940126657 Compound 17 Drugs 0.000 description 2
- 229940126639 Compound 33 Drugs 0.000 description 2
- 229940127007 Compound 39 Drugs 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010022491 Insulin resistant diabetes Diseases 0.000 description 2
- 102000015696 Interleukins Human genes 0.000 description 2
- 108010063738 Interleukins Proteins 0.000 description 2
- 108010044467 Isoenzymes Proteins 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- AVYVHIKSFXVDBG-UHFFFAOYSA-N N-benzyl-N-hydroxy-2,2-dimethylbutanamide Chemical compound C(C1=CC=CC=C1)N(C(C(CC)(C)C)=O)O AVYVHIKSFXVDBG-UHFFFAOYSA-N 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- POFVJRKJJBFPII-UHFFFAOYSA-N N-cyclopentyl-5-[2-[[5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl]amino]-5-fluoropyrimidin-4-yl]-4-methyl-1,3-thiazol-2-amine Chemical compound C1(CCCC1)NC=1SC(=C(N=1)C)C1=NC(=NC=C1F)NC1=NC=C(C=C1)CN1CCN(CC1)CC POFVJRKJJBFPII-UHFFFAOYSA-N 0.000 description 2
- QOVYHDHLFPKQQG-NDEPHWFRSA-N N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O Chemical compound N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O QOVYHDHLFPKQQG-NDEPHWFRSA-N 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 108010058846 Ovalbumin Proteins 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 201000004681 Psoriasis Diseases 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- PNUZDKCDAWUEGK-CYZMBNFOSA-N Sitafloxacin Chemical compound C([C@H]1N)N(C=2C(=C3C(C(C(C(O)=O)=CN3[C@H]3[C@H](C3)F)=O)=CC=2F)Cl)CC11CC1 PNUZDKCDAWUEGK-CYZMBNFOSA-N 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- LJOOWESTVASNOG-UFJKPHDISA-N [(1s,3r,4ar,7s,8s,8as)-3-hydroxy-8-[2-[(4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1[C@@H](C)C=C[C@H]2C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)CC1C[C@@H](O)CC(=O)O1 LJOOWESTVASNOG-UFJKPHDISA-N 0.000 description 2
- SPXSEZMVRJLHQG-XMMPIXPASA-N [(2R)-1-[[4-[(3-phenylmethoxyphenoxy)methyl]phenyl]methyl]pyrrolidin-2-yl]methanol Chemical compound C(C1=CC=CC=C1)OC=1C=C(OCC2=CC=C(CN3[C@H](CCC3)CO)C=C2)C=CC=1 SPXSEZMVRJLHQG-XMMPIXPASA-N 0.000 description 2
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 229960005305 adenosine Drugs 0.000 description 2
- QBYJBZPUGVGKQQ-SJJAEHHWSA-N aldrin Chemical compound C1[C@H]2C=C[C@@H]1[C@H]1[C@@](C3(Cl)Cl)(Cl)C(Cl)=C(Cl)[C@@]3(Cl)[C@H]12 QBYJBZPUGVGKQQ-SJJAEHHWSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 230000002052 anaphylactic effect Effects 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 235000019568 aromas Nutrition 0.000 description 2
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 description 2
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 2
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- FUSUHKVFWTUUBE-UHFFFAOYSA-N buten-2-one Chemical compound CC(=O)C=C FUSUHKVFWTUUBE-UHFFFAOYSA-N 0.000 description 2
- 235000011089 carbon dioxide Nutrition 0.000 description 2
- 210000001715 carotid artery Anatomy 0.000 description 2
- VZWXIQHBIQLMPN-UHFFFAOYSA-N chromane Chemical compound C1=CC=C2CCCOC2=C1 VZWXIQHBIQLMPN-UHFFFAOYSA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 229940125904 compound 1 Drugs 0.000 description 2
- 229940126543 compound 14 Drugs 0.000 description 2
- 229940125758 compound 15 Drugs 0.000 description 2
- 229940126142 compound 16 Drugs 0.000 description 2
- 229940126208 compound 22 Drugs 0.000 description 2
- 229940125833 compound 23 Drugs 0.000 description 2
- 229940125961 compound 24 Drugs 0.000 description 2
- 229940125846 compound 25 Drugs 0.000 description 2
- 229940125851 compound 27 Drugs 0.000 description 2
- 229940127204 compound 29 Drugs 0.000 description 2
- 229940126214 compound 3 Drugs 0.000 description 2
- 229940125877 compound 31 Drugs 0.000 description 2
- 229940125878 compound 36 Drugs 0.000 description 2
- 229940125807 compound 37 Drugs 0.000 description 2
- 229940127573 compound 38 Drugs 0.000 description 2
- 229940126540 compound 41 Drugs 0.000 description 2
- 229940125936 compound 42 Drugs 0.000 description 2
- 229940127271 compound 49 Drugs 0.000 description 2
- 229940126179 compound 72 Drugs 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- BJXYHBKEQFQVES-NWDGAFQWSA-N enpatoran Chemical compound N[C@H]1CN(C[C@H](C1)C(F)(F)F)C1=C2C=CC=NC2=C(C=C1)C#N BJXYHBKEQFQVES-NWDGAFQWSA-N 0.000 description 2
- KYXIIALFZFVHHZ-UHFFFAOYSA-N ethyl 2-(4-formyl-7-methoxy-1-benzofuran-3-yl)acetate Chemical compound C1=CC(C=O)=C2C(CC(=O)OCC)=COC2=C1OC KYXIIALFZFVHHZ-UHFFFAOYSA-N 0.000 description 2
- 229960004979 fampridine Drugs 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000011597 hartley guinea pig Methods 0.000 description 2
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine hydrate Chemical compound O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 2
- RCBVKBFIWMOMHF-UHFFFAOYSA-L hydroxy-(hydroxy(dioxo)chromio)oxy-dioxochromium;pyridine Chemical compound C1=CC=NC=C1.C1=CC=NC=C1.O[Cr](=O)(=O)O[Cr](O)(=O)=O RCBVKBFIWMOMHF-UHFFFAOYSA-L 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 238000012417 linear regression Methods 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- RENRQMCACQEWFC-UGKGYDQZSA-N lnp023 Chemical compound C1([C@H]2N(CC=3C=4C=CNC=4C(C)=CC=3OC)CC[C@@H](C2)OCC)=CC=C(C(O)=O)C=C1 RENRQMCACQEWFC-UGKGYDQZSA-N 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000002184 metal Chemical class 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- YIBBRIBBBSRZDT-UHFFFAOYSA-N methyl 2-(2-ethylbut-2-enyl)-3-hydroxy-4-methoxybenzoate Chemical compound CCC(=CC)CC1=C(O)C(OC)=CC=C1C(=O)OC YIBBRIBBBSRZDT-UHFFFAOYSA-N 0.000 description 2
- RFOUCWBINJFMGT-UHFFFAOYSA-N methyl 4-methoxy-3-(3-oxopentan-2-yloxy)benzoate Chemical compound CCC(=O)C(C)OC1=CC(C(=O)OC)=CC=C1OC RFOUCWBINJFMGT-UHFFFAOYSA-N 0.000 description 2
- GMDNTWCAOHFEPI-UHFFFAOYSA-N methyl 7-methoxy-2-(2-methylpropyl)-1-benzofuran-4-carboxylate Chemical compound COC(=O)C1=CC=C(OC)C2=C1C=C(CC(C)C)O2 GMDNTWCAOHFEPI-UHFFFAOYSA-N 0.000 description 2
- QONWMYIHPLYRGX-UHFFFAOYSA-N methyl 7-methoxy-2-phenyl-1-benzofuran-4-carboxylate Chemical compound C=1C=2C(C(=O)OC)=CC=C(OC)C=2OC=1C1=CC=CC=C1 QONWMYIHPLYRGX-UHFFFAOYSA-N 0.000 description 2
- KFUFQMSBTDKULL-UHFFFAOYSA-N methyl 7-methoxy-2-pyridin-4-yl-1-benzofuran-4-carboxylate Chemical compound C=1C=2C(C(=O)OC)=CC=C(OC)C=2OC=1C1=CC=NC=C1 KFUFQMSBTDKULL-UHFFFAOYSA-N 0.000 description 2
- JIKUXBYRTXDNIY-UHFFFAOYSA-N n-methyl-n-phenylformamide Chemical compound O=CN(C)C1=CC=CC=C1 JIKUXBYRTXDNIY-UHFFFAOYSA-N 0.000 description 2
- 239000007922 nasal spray Substances 0.000 description 2
- 229940097496 nasal spray Drugs 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- PIDFDZJZLOTZTM-KHVQSSSXSA-N ombitasvir Chemical compound COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC1=CC=C([C@H]2N([C@@H](CC2)C=2C=CC(NC(=O)[C@H]3N(CCC3)C(=O)[C@@H](NC(=O)OC)C(C)C)=CC=2)C=2C=CC(=CC=2)C(C)(C)C)C=C1 PIDFDZJZLOTZTM-KHVQSSSXSA-N 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000004014 plasticizer Substances 0.000 description 2
- 125000005592 polycycloalkyl group Polymers 0.000 description 2
- RPDAUEIUDPHABB-UHFFFAOYSA-N potassium ethoxide Chemical compound [K+].CC[O-] RPDAUEIUDPHABB-UHFFFAOYSA-N 0.000 description 2
- 239000012286 potassium permanganate Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 210000005090 tracheal smooth muscle Anatomy 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- DBGVGMSCBYYSLD-UHFFFAOYSA-N tributylstannane Chemical compound CCCC[SnH](CCCC)CCCC DBGVGMSCBYYSLD-UHFFFAOYSA-N 0.000 description 2
- PYOKUURKVVELLB-UHFFFAOYSA-N trimethyl orthoformate Chemical compound COC(OC)OC PYOKUURKVVELLB-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- 102000003390 tumor necrosis factor Human genes 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- KDDNKZCVYQDGKE-UHFFFAOYSA-N (2-chlorophenyl)methanamine Chemical compound NCC1=CC=CC=C1Cl KDDNKZCVYQDGKE-UHFFFAOYSA-N 0.000 description 1
- YMVFJGSXZNNUDW-UHFFFAOYSA-N (4-chlorophenyl)methanamine Chemical compound NCC1=CC=C(Cl)C=C1 YMVFJGSXZNNUDW-UHFFFAOYSA-N 0.000 description 1
- IIFVWLUQBAIPMJ-UHFFFAOYSA-N (4-fluorophenyl)methanamine Chemical compound NCC1=CC=C(F)C=C1 IIFVWLUQBAIPMJ-UHFFFAOYSA-N 0.000 description 1
- FCQRLHQHKFKTQE-HCTDMSSWSA-N (4r)-4-[(3r,5r,8r,9s,10s,13r,14s,17r)-3-acetyloxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoic acid Chemical compound C([C@H]1CC2)[C@H](OC(C)=O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 FCQRLHQHKFKTQE-HCTDMSSWSA-N 0.000 description 1
- LQFSOUIYMJLSCP-WDEREUQCSA-N (5ar,9ar)-4-methoxy-5a,6,7,8,9,9a-hexahydrodibenzofuran-1-carbaldehyde Chemical compound C([C@@H]12)CCC[C@H]1OC1=C2C(C=O)=CC=C1OC LQFSOUIYMJLSCP-WDEREUQCSA-N 0.000 description 1
- OGCYVVHVSQTTIK-UHFFFAOYSA-N (7-methoxy-1-benzofuran-2-yl)-phenylmethanone Chemical compound O1C=2C(OC)=CC=CC=2C=C1C(=O)C1=CC=CC=C1 OGCYVVHVSQTTIK-UHFFFAOYSA-N 0.000 description 1
- FYCWSOPNJAPBPA-UHFFFAOYSA-N (7-methoxy-2,2-dimethyl-3h-1-benzofuran-4-yl)-phenylmethanone Chemical compound C1=2CC(C)(C)OC=2C(OC)=CC=C1C(=O)C1=CC=CC=C1 FYCWSOPNJAPBPA-UHFFFAOYSA-N 0.000 description 1
- ODVXFPBBGVOPNO-UHFFFAOYSA-N (7-methoxy-2-pyridin-4-yl-1-benzofuran-4-yl)-phenylmethanone Chemical compound C1=2C=C(C=3C=CN=CC=3)OC=2C(OC)=CC=C1C(=O)C1=CC=CC=C1 ODVXFPBBGVOPNO-UHFFFAOYSA-N 0.000 description 1
- MPNQVHUTPJAZPD-UHFFFAOYSA-N (7-methoxy-3-methyl-2,3-dihydro-1-benzofuran-4-yl)-phenylmethanol Chemical compound C1=2C(C)COC=2C(OC)=CC=C1C(O)C1=CC=CC=C1 MPNQVHUTPJAZPD-UHFFFAOYSA-N 0.000 description 1
- FQCSEGXNFDLUNC-UHFFFAOYSA-N (7-methoxy-3-methyl-2,3-dihydro-1-benzofuran-4-yl)-phenylmethanone Chemical compound C1=2C(C)COC=2C(OC)=CC=C1C(=O)C1=CC=CC=C1 FQCSEGXNFDLUNC-UHFFFAOYSA-N 0.000 description 1
- XJRHAOKSESUTJJ-UHFFFAOYSA-N (7-methoxyspiro[1,3-benzodioxole-2,1'-cyclopentane]-4-yl)-phenylmethanone Chemical compound C1=2OC3(CCCC3)OC=2C(OC)=CC=C1C(=O)C1=CC=CC=C1 XJRHAOKSESUTJJ-UHFFFAOYSA-N 0.000 description 1
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 description 1
- AVMHMVJVHYGDOO-NSCUHMNNSA-N (e)-1-bromobut-2-ene Chemical compound C\C=C\CBr AVMHMVJVHYGDOO-NSCUHMNNSA-N 0.000 description 1
- ILYXOZBXAOYWDB-GDNBJRDFSA-N (e)-3-(7-methoxy-2,2-dimethyl-3h-1-benzofuran-4-yl)-2-pyridin-4-ylprop-2-enenitrile Chemical compound C1=2CC(C)(C)OC=2C(OC)=CC=C1\C=C(\C#N)C1=CC=NC=C1 ILYXOZBXAOYWDB-GDNBJRDFSA-N 0.000 description 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- FTNJQNQLEGKTGD-UHFFFAOYSA-N 1,3-benzodioxole Chemical compound C1=CC=C2OCOC2=C1 FTNJQNQLEGKTGD-UHFFFAOYSA-N 0.000 description 1
- IDPURXSQCKYKIJ-UHFFFAOYSA-N 1-(4-methoxyphenyl)methanamine Chemical compound COC1=CC=C(CN)C=C1 IDPURXSQCKYKIJ-UHFFFAOYSA-N 0.000 description 1
- GXIDZJJZAFYEGA-UHFFFAOYSA-N 1-(4-methoxyspiro[3h-1-benzofuran-2,1'-cyclopentane]-7-yl)-2-pyridin-4-ylethanone Chemical compound C1=2OC3(CCCC3)CC=2C(OC)=CC=C1C(=O)CC1=CC=NC=C1 GXIDZJJZAFYEGA-UHFFFAOYSA-N 0.000 description 1
- XOTLUYZUFKFHHN-UHFFFAOYSA-N 1-(7-methoxy-2,2-dimethyl-3h-1-benzofuran-4-yl)ethanol Chemical compound COC1=CC=C(C(C)O)C2=C1OC(C)(C)C2 XOTLUYZUFKFHHN-UHFFFAOYSA-N 0.000 description 1
- PDVASUPVCZJHEB-UHFFFAOYSA-N 1-(7-methoxy-2,2-dimethyl-3h-1-benzofuran-4-yl)ethanone Chemical compound COC1=CC=C(C(C)=O)C2=C1OC(C)(C)C2 PDVASUPVCZJHEB-UHFFFAOYSA-N 0.000 description 1
- KSYMHPBMRJNZHX-UHFFFAOYSA-N 1-(7-methoxy-2-phenyl-1-benzofuran-4-yl)-2-pyridin-4-ylethanol Chemical compound C1=2C=C(C=3C=CC=CC=3)OC=2C(OC)=CC=C1C(O)CC1=CC=NC=C1 KSYMHPBMRJNZHX-UHFFFAOYSA-N 0.000 description 1
- YPTCXHLYVZZZCA-UHFFFAOYSA-N 1-(7-methoxy-2-pyridin-2-yl-1-benzofuran-4-yl)-2-pyridin-4-ylethanol Chemical compound C1=2C=C(C=3N=CC=CC=3)OC=2C(OC)=CC=C1C(O)CC1=CC=NC=C1 YPTCXHLYVZZZCA-UHFFFAOYSA-N 0.000 description 1
- YWOYYASSWJCRKZ-UHFFFAOYSA-N 1-(7-methoxy-2-pyridin-2-yl-1-benzofuran-4-yl)-2-pyridin-4-ylethanone Chemical compound C1=2C=C(C=3N=CC=CC=3)OC=2C(OC)=CC=C1C(=O)CC1=CC=NC=C1 YWOYYASSWJCRKZ-UHFFFAOYSA-N 0.000 description 1
- SDPYSDXEDLOXHW-UHFFFAOYSA-N 1-(7-methoxy-2-pyridin-4-yl-1-benzofuran-4-yl)-2-pyridin-4-ylethanol Chemical compound C1=2C=C(C=3C=CN=CC=3)OC=2C(OC)=CC=C1C(O)CC1=CC=NC=C1 SDPYSDXEDLOXHW-UHFFFAOYSA-N 0.000 description 1
- OBSTYSSFIPKMGY-UHFFFAOYSA-N 1-(7-methoxy-3-phenyl-1-benzofuran-4-yl)-2-pyridin-4-ylethanone Chemical compound C1=2C(C=3C=CC=CC=3)=COC=2C(OC)=CC=C1C(=O)CC1=CC=NC=C1 OBSTYSSFIPKMGY-UHFFFAOYSA-N 0.000 description 1
- OOEAPQPYSIINOT-UHFFFAOYSA-N 1-(7-methoxyspiro[3h-1-benzofuran-2,1'-cyclopentane]-4-yl)ethanol Chemical compound O1C=2C(OC)=CC=C(C(C)O)C=2CC21CCCC2 OOEAPQPYSIINOT-UHFFFAOYSA-N 0.000 description 1
- KSQQPFBPOXLHLZ-UHFFFAOYSA-N 1-(7-methoxyspiro[3h-1-benzofuran-2,1'-cyclopentane]-4-yl)ethanone Chemical compound O1C=2C(OC)=CC=C(C(C)=O)C=2CC21CCCC2 KSQQPFBPOXLHLZ-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- KJVZVHLDXNSLAS-DOTOQJQBSA-N 1-[(5ar,9ar)-4-methoxy-5a,6,7,8,9,9a-hexahydrodibenzofuran-1-yl]-2-pyridin-4-ylethanone Chemical compound O([C@@H]1CCCC[C@@H]1C=12)C=1C(OC)=CC=C2C(=O)CC1=CC=NC=C1 KJVZVHLDXNSLAS-DOTOQJQBSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- RYOCKWJUBBAWPM-UHFFFAOYSA-N 1-[2-(7-methoxy-1-benzofuran-2-yl)phenyl]ethanol Chemical compound O1C=2C(OC)=CC=CC=2C=C1C1=CC=CC=C1C(C)O RYOCKWJUBBAWPM-UHFFFAOYSA-N 0.000 description 1
- IWYRSFBUMNAGGJ-UHFFFAOYSA-N 1-[7-methoxy-2-(2-methylpropyl)-1-benzofuran-4-yl]-2-pyridin-4-ylethanone Chemical compound C1=2C=C(CC(C)C)OC=2C(OC)=CC=C1C(=O)CC1=CC=NC=C1 IWYRSFBUMNAGGJ-UHFFFAOYSA-N 0.000 description 1
- RXXRRSKXZISRSK-UHFFFAOYSA-N 1-[7-methoxy-2-(2-propan-2-ylphenyl)-1-benzofuran-4-yl]-2-pyridin-4-ylethanone Chemical compound C1=2C=C(C=3C(=CC=CC=3)C(C)C)OC=2C(OC)=CC=C1C(=O)CC1=CC=NC=C1 RXXRRSKXZISRSK-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- XYPISWUKQGWYGX-UHFFFAOYSA-N 2,2,2-trifluoroethaneperoxoic acid Chemical compound OOC(=O)C(F)(F)F XYPISWUKQGWYGX-UHFFFAOYSA-N 0.000 description 1
- HBEDSQVIWPRPAY-UHFFFAOYSA-N 2,3-dihydrobenzofuran Chemical class C1=CC=C2OCCC2=C1 HBEDSQVIWPRPAY-UHFFFAOYSA-N 0.000 description 1
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 1
- WGFNXGPBPIJYLI-UHFFFAOYSA-N 2,6-difluoro-3-[(3-fluorophenyl)sulfonylamino]-n-(3-methoxy-1h-pyrazolo[3,4-b]pyridin-5-yl)benzamide Chemical compound C1=C2C(OC)=NNC2=NC=C1NC(=O)C(C=1F)=C(F)C=CC=1NS(=O)(=O)C1=CC=CC(F)=C1 WGFNXGPBPIJYLI-UHFFFAOYSA-N 0.000 description 1
- BVYMNRUMICJZFB-UHFFFAOYSA-N 2-(2-bromo-5-methoxyphenoxy)cyclopentan-1-one Chemical compound COC1=CC=C(Br)C(OC2C(CCC2)=O)=C1 BVYMNRUMICJZFB-UHFFFAOYSA-N 0.000 description 1
- ZAXGGZIDYRSKLZ-UHFFFAOYSA-N 2-(3,5-dichloropyridin-4-yl)-1-(7-methoxy-3-methyl-2,3-dihydro-1-benzofuran-4-yl)ethanone Chemical compound C1=2C(C)COC=2C(OC)=CC=C1C(=O)CC1=C(Cl)C=NC=C1Cl ZAXGGZIDYRSKLZ-UHFFFAOYSA-N 0.000 description 1
- MRVXCMUCJGSIQS-UHFFFAOYSA-N 2-(7-methoxyspiro[3h-1-benzofuran-2,1'-cyclopentane]-4-yl)-2-methyl-3-pyridin-4-ylpropanenitrile Chemical compound O1C=2C(OC)=CC=C(C(C)(CC=3C=CN=CC=3)C#N)C=2CC21CCCC2 MRVXCMUCJGSIQS-UHFFFAOYSA-N 0.000 description 1
- JPMRGPPMXHGKRO-UHFFFAOYSA-N 2-(chloromethyl)pyridine hydrochloride Chemical compound Cl.ClCC1=CC=CC=N1 JPMRGPPMXHGKRO-UHFFFAOYSA-N 0.000 description 1
- HNEQYNCIWQQMER-UHFFFAOYSA-N 2-[(7-methoxy-2,2-dimethyl-3h-1-benzofuran-4-yl)methylidene]propanedinitrile Chemical compound COC1=CC=C(C=C(C#N)C#N)C2=C1OC(C)(C)C2 HNEQYNCIWQQMER-UHFFFAOYSA-N 0.000 description 1
- YPMFRXTVPVQZFD-UHFFFAOYSA-N 2-[4-(cyclohexylcarbamoyl)-7-methoxy-2,3-dihydro-1-benzofuran-3-yl]acetic acid Chemical compound C1=2C(CC(O)=O)COC=2C(OC)=CC=C1C(=O)NC1CCCCC1 YPMFRXTVPVQZFD-UHFFFAOYSA-N 0.000 description 1
- YWFNBPYGEAVWAK-UHFFFAOYSA-N 2-[4-[(3,5-dichloropyridin-4-yl)carbamoyl]-7-methoxy-1-benzofuran-3-yl]acetic acid Chemical compound C1=2C(CC(O)=O)=COC=2C(OC)=CC=C1C(=O)NC1=C(Cl)C=NC=C1Cl YWFNBPYGEAVWAK-UHFFFAOYSA-N 0.000 description 1
- NYFJMJXUDKYZPA-UHFFFAOYSA-N 2-[4-[(7-methoxy-2,3-dihydro-1-benzofuran-2-carbonyl)amino]pyridin-3-yl]acetic acid Chemical compound C(=O)(O)CC=1C=NC=CC=1NC(=O)C1OC2=C(C1)C=CC=C2OC NYFJMJXUDKYZPA-UHFFFAOYSA-N 0.000 description 1
- ALDSSKVVKJJIJB-UHFFFAOYSA-N 2-[7-methoxy-4-(phenylcarbamoyl)-2,3-dihydro-1-benzofuran-3-yl]acetic acid Chemical compound C1=2C(CC(O)=O)COC=2C(OC)=CC=C1C(=O)NC1=CC=CC=C1 ALDSSKVVKJJIJB-UHFFFAOYSA-N 0.000 description 1
- AJTVSSFTXWNIRG-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanesulfonic acid Chemical compound OCC[NH+](CCO)CCS([O-])(=O)=O AJTVSSFTXWNIRG-UHFFFAOYSA-N 0.000 description 1
- JTXMVXSTHSMVQF-UHFFFAOYSA-N 2-acetyloxyethyl acetate Chemical compound CC(=O)OCCOC(C)=O JTXMVXSTHSMVQF-UHFFFAOYSA-N 0.000 description 1
- SLNNXGOFCOXCEW-UHFFFAOYSA-N 2-benzyl-7-methoxy-1-benzofuran Chemical compound O1C=2C(OC)=CC=CC=2C=C1CC1=CC=CC=C1 SLNNXGOFCOXCEW-UHFFFAOYSA-N 0.000 description 1
- HXMKQHSNSWDJKS-UHFFFAOYSA-N 2-benzyl-7-methoxy-1-benzofuran-4-carbaldehyde Chemical compound O1C=2C(OC)=CC=C(C=O)C=2C=C1CC1=CC=CC=C1 HXMKQHSNSWDJKS-UHFFFAOYSA-N 0.000 description 1
- RYNWWCVMEWXBBZ-UHFFFAOYSA-N 2-benzyl-n-(3,5-dichloropyridin-4-yl)-7-methoxy-1-benzofuran-4-carboxamide Chemical compound C1=2C=C(CC=3C=CC=CC=3)OC=2C(OC)=CC=C1C(=O)NC1=C(Cl)C=NC=C1Cl RYNWWCVMEWXBBZ-UHFFFAOYSA-N 0.000 description 1
- KHGMUWBYGFWGCZ-UHFFFAOYSA-N 2-bromo-5-methoxyphenol Chemical compound COC1=CC=C(Br)C(O)=C1 KHGMUWBYGFWGCZ-UHFFFAOYSA-N 0.000 description 1
- QLTNNOHLTVAGCC-UHFFFAOYSA-N 2-butyl-7-methoxy-1-benzofuran Chemical compound C1=CC(OC)=C2OC(CCCC)=CC2=C1 QLTNNOHLTVAGCC-UHFFFAOYSA-N 0.000 description 1
- PIZRRMWJIQQORV-UHFFFAOYSA-N 2-butyl-7-methoxy-1-benzofuran-4-carbaldehyde Chemical compound C1=CC(OC)=C2OC(CCCC)=CC2=C1C=O PIZRRMWJIQQORV-UHFFFAOYSA-N 0.000 description 1
- KJSACBIEOWLHMW-UHFFFAOYSA-N 2-butyl-7-methoxy-1-benzofuran-4-carboxylic acid Chemical compound C1=CC(OC)=C2OC(CCCC)=CC2=C1C(O)=O KJSACBIEOWLHMW-UHFFFAOYSA-N 0.000 description 1
- CCHNWURRBFGQCD-UHFFFAOYSA-N 2-chlorocyclohexan-1-one Chemical compound ClC1CCCCC1=O CCHNWURRBFGQCD-UHFFFAOYSA-N 0.000 description 1
- AXDZFGRFZOQVBV-UHFFFAOYSA-N 2-chlorocyclopentan-1-one Chemical compound ClC1CCCC1=O AXDZFGRFZOQVBV-UHFFFAOYSA-N 0.000 description 1
- VQJYYJGBMJVPEX-UHFFFAOYSA-N 2-cyano-7-methoxy-1-benzofuran-4-carboxylic acid Chemical compound COC1=CC=C(C(O)=O)C2=C1OC(C#N)=C2 VQJYYJGBMJVPEX-UHFFFAOYSA-N 0.000 description 1
- XRXANEMIFVRKLN-UHFFFAOYSA-N 2-hydroperoxy-2-methylbutane Chemical compound CCC(C)(C)OO XRXANEMIFVRKLN-UHFFFAOYSA-N 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical class CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- VMZCDNSFRSVYKQ-UHFFFAOYSA-N 2-phenylacetyl chloride Chemical compound ClC(=O)CC1=CC=CC=C1 VMZCDNSFRSVYKQ-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- PAEXAIBDCHBNDC-UHFFFAOYSA-N 2-pyridin-4-ylacetic acid Chemical compound OC(=O)CC1=CC=NC=C1 PAEXAIBDCHBNDC-UHFFFAOYSA-N 0.000 description 1
- KOTOBGUEHPZPNB-GQCTYLIASA-N 3,5-dichloro-4-[(e)-2-(7-methoxy-2,2-dimethyl-3h-1-benzofuran-4-yl)ethenyl]pyridine Chemical compound C1=2CC(C)(C)OC=2C(OC)=CC=C1\C=C\C1=C(Cl)C=NC=C1Cl KOTOBGUEHPZPNB-GQCTYLIASA-N 0.000 description 1
- ZQEKVEORZPCDFI-DUXPYHPUSA-N 3,5-dichloro-4-[(e)-2-(7-methoxy-2-pyridin-4-yl-1-benzofuran-4-yl)ethenyl]pyridine Chemical compound C1=2C=C(C=3C=CN=CC=3)OC=2C(OC)=CC=C1\C=C\C1=C(Cl)C=NC=C1Cl ZQEKVEORZPCDFI-DUXPYHPUSA-N 0.000 description 1
- RICFPAIOQXLZBI-HWKANZROSA-N 3,5-dichloro-4-[(e)-2-(7-methoxy-3-methyl-2,3-dihydro-1-benzofuran-4-yl)ethenyl]pyridine Chemical compound C1=2C(C)COC=2C(OC)=CC=C1\C=C\C1=C(Cl)C=NC=C1Cl RICFPAIOQXLZBI-HWKANZROSA-N 0.000 description 1
- NJPGCQQRHWTVNY-GQCTYLIASA-N 3,5-dichloro-4-[(e)-2-(7-methoxyspiro[3h-1-benzofuran-2,1'-cyclopentane]-4-yl)ethenyl]pyridine Chemical compound C1=2CC3(CCCC3)OC=2C(OC)=CC=C1\C=C\C1=C(Cl)C=NC=C1Cl NJPGCQQRHWTVNY-GQCTYLIASA-N 0.000 description 1
- DLYCYOQOTJTNTE-UHFFFAOYSA-N 3,5-dichloro-4-[2-(2,2-diethyl-7-methoxy-3h-1-benzofuran-4-yl)ethyl]pyridine Chemical compound O1C(CC)(CC)CC2=C1C(OC)=CC=C2CCC1=C(Cl)C=NC=C1Cl DLYCYOQOTJTNTE-UHFFFAOYSA-N 0.000 description 1
- YVRSBDCAMISLFH-UHFFFAOYSA-N 3,5-dichloro-4-[2-(7-methoxy-2,2-dimethyl-3h-1-benzofuran-4-yl)ethyl]pyridine Chemical compound C1=2CC(C)(C)OC=2C(OC)=CC=C1CCC1=C(Cl)C=NC=C1Cl YVRSBDCAMISLFH-UHFFFAOYSA-N 0.000 description 1
- AJIHYLMARBCLIH-UHFFFAOYSA-N 3,5-dichloro-4-[2-(7-methoxyspiro[1,3-benzodioxole-2,1'-cyclopentane]-4-yl)ethenyl]pyridine Chemical compound C1=2OC3(CCCC3)OC=2C(OC)=CC=C1C=CC1=C(Cl)C=NC=C1Cl AJIHYLMARBCLIH-UHFFFAOYSA-N 0.000 description 1
- QHUCIHGBZQDNFE-UHFFFAOYSA-N 3,5-dichloro-4-[2-methoxy-2-(7-methoxy-2,2-dimethyl-3h-1-benzofuran-4-yl)ethyl]pyridine Chemical compound C=1C=C(OC)C=2OC(C)(C)CC=2C=1C(OC)CC1=C(Cl)C=NC=C1Cl QHUCIHGBZQDNFE-UHFFFAOYSA-N 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- QCRFAPSMGHLWOY-UHFFFAOYSA-N 3-(2-ethoxy-2-oxoethyl)-7-methoxy-1-benzofuran-4-carboxylic acid Chemical compound C1=CC(C(O)=O)=C2C(CC(=O)OCC)=COC2=C1OC QCRFAPSMGHLWOY-UHFFFAOYSA-N 0.000 description 1
- RVACEAGTKSROKR-UHFFFAOYSA-N 3-(2-ethoxy-2-oxoethyl)-7-methoxy-2,3-dihydro-1-benzofuran-4-carboxylic acid Chemical compound OC(=O)C1=CC=C(OC)C2=C1C(CC(=O)OCC)CO2 RVACEAGTKSROKR-UHFFFAOYSA-N 0.000 description 1
- AQQGIPSKOHNXAG-UHFFFAOYSA-N 3-(3,5-dichloropyridin-4-yl)-2-(7-methoxy-2,2-dimethyl-3h-1-benzofuran-4-yl)propanenitrile Chemical compound C1=2CC(C)(C)OC=2C(OC)=CC=C1C(C#N)CC1=C(Cl)C=NC=C1Cl AQQGIPSKOHNXAG-UHFFFAOYSA-N 0.000 description 1
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 1
- OHXAOPZTJOUYKM-UHFFFAOYSA-N 3-Chloro-2-methylpropene Chemical compound CC(=C)CCl OHXAOPZTJOUYKM-UHFFFAOYSA-N 0.000 description 1
- KGEJYDNFYCMSQD-UHFFFAOYSA-N 3-[2-(benzylamino)-2-oxoethyl]-n-(3,5-dichloropyridin-4-yl)-7-methoxy-2,3-dihydro-1-benzofuran-4-carboxamide Chemical compound C1=2C(CC(=O)NCC=3C=CC=CC=3)COC=2C(OC)=CC=C1C(=O)NC1=C(Cl)C=NC=C1Cl KGEJYDNFYCMSQD-UHFFFAOYSA-N 0.000 description 1
- FKUYUYNPDVUHJA-UHFFFAOYSA-N 3-[2-[(4-chlorophenyl)methylamino]-2-oxoethyl]-n-(3,5-dichloropyridin-4-yl)-7-methoxy-2,3-dihydro-1-benzofuran-4-carboxamide Chemical compound C1=2C(CC(=O)NCC=3C=CC(Cl)=CC=3)COC=2C(OC)=CC=C1C(=O)NC1=C(Cl)C=NC=C1Cl FKUYUYNPDVUHJA-UHFFFAOYSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- NVBCFOQYDFKXJJ-UHFFFAOYSA-N 3-formyl-1h-indole-5-carbonitrile Chemical compound C1=C(C#N)C=C2C(C=O)=CNC2=C1 NVBCFOQYDFKXJJ-UHFFFAOYSA-N 0.000 description 1
- KLXKKFGRNPBWGM-UHFFFAOYSA-N 3-hydroxy-2-iodo-4-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C(I)=C1O KLXKKFGRNPBWGM-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- QNKRXSIKBQRTMB-UHFFFAOYSA-N 4-N-(3,5-dichloropyridin-4-yl)-7-methoxy-3-N-[(4-methoxyphenyl)methyl]-2-methyl-2,3-dihydro-1-benzofuran-3,4-dicarboxamide Chemical compound ClC=1C=NC=C(C=1NC(=O)C1=CC=C(C2=C1C(C(O2)C)C(=O)NCC1=CC=C(C=C1)OC)OC)Cl QNKRXSIKBQRTMB-UHFFFAOYSA-N 0.000 description 1
- DRTGFICZXDCIMI-UHFFFAOYSA-N 4-[(7-methoxy-2,2-dimethyl-3h-1-benzofuran-4-yl)methylsulfanyl]pyridine Chemical compound C1=2CC(C)(C)OC=2C(OC)=CC=C1CSC1=CC=NC=C1 DRTGFICZXDCIMI-UHFFFAOYSA-N 0.000 description 1
- GHKOLHXGAMTLIG-VOTSOKGWSA-N 4-[(e)-2-(2,2-diethyl-7-methoxy-3h-1-benzofuran-4-yl)ethenyl]pyridine Chemical compound O1C(CC)(CC)CC2=C1C(OC)=CC=C2\C=C\C1=CC=NC=C1 GHKOLHXGAMTLIG-VOTSOKGWSA-N 0.000 description 1
- DLJOJLIPVFTMLN-SNAWJCMRSA-N 4-[(e)-2-(7-methoxy-2,2-dimethyl-3h-1-benzofuran-4-yl)ethenyl]pyridine Chemical compound C1=2CC(C)(C)OC=2C(OC)=CC=C1\C=C\C1=CC=NC=C1 DLJOJLIPVFTMLN-SNAWJCMRSA-N 0.000 description 1
- XTBYQFMELXHODD-NSCUHMNNSA-N 4-[(e)-2-(7-methoxy-2-pyridin-4-yl-1-benzofuran-4-yl)ethenyl]pyridine Chemical compound C1=2C=C(C=3C=CN=CC=3)OC=2C(OC)=CC=C1\C=C\C1=CC=NC=C1 XTBYQFMELXHODD-NSCUHMNNSA-N 0.000 description 1
- ORXINFPUHLOWKJ-UHFFFAOYSA-N 4-[2-(3,5-dichloropyridin-4-yl)-1-hydroxyethyl]-7-methoxy-1-benzofuran-2-carbonitrile Chemical compound C1=2C=C(C#N)OC=2C(OC)=CC=C1C(O)CC1=C(Cl)C=NC=C1Cl ORXINFPUHLOWKJ-UHFFFAOYSA-N 0.000 description 1
- QONWZWFWNWLDKZ-UHFFFAOYSA-N 4-[2-(7,7-dimethoxy-2,2-dimethyl-3,6-dihydro-1-benzofuran-4-yl)-2-phenylethyl]pyridine Chemical compound O1C(C)(C)CC2=C1C(OC)(OC)CC=C2C(C=1C=CC=CC=1)CC1=CC=NC=C1 QONWZWFWNWLDKZ-UHFFFAOYSA-N 0.000 description 1
- UBQIPQHGTMPAPE-UHFFFAOYSA-N 4-[2-(7-methoxy-2,2-dimethyl-3h-1-benzofuran-4-yl)ethyl]pyridine Chemical compound C1=2CC(C)(C)OC=2C(OC)=CC=C1CCC1=CC=NC=C1 UBQIPQHGTMPAPE-UHFFFAOYSA-N 0.000 description 1
- OSKABORCRNISQH-UHFFFAOYSA-N 4-[2-(7-methoxy-2,2-dimethyl-3h-1-benzofuran-4-yl)prop-1-enyl]pyridine Chemical compound C1=2CC(C)(C)OC=2C(OC)=CC=C1C(C)=CC1=CC=NC=C1 OSKABORCRNISQH-UHFFFAOYSA-N 0.000 description 1
- UQSUNSGSQPZHBZ-UHFFFAOYSA-N 4-[2-(7-methoxy-3-methyl-2,3-dihydro-1-benzofuran-4-yl)-2-phenylethyl]pyridine Chemical compound C1=2C(C)COC=2C(OC)=CC=C1C(C=1C=CC=CC=1)CC1=CC=NC=C1 UQSUNSGSQPZHBZ-UHFFFAOYSA-N 0.000 description 1
- XDFSBYSVMCFOGR-UHFFFAOYSA-N 4-[2-(7-methoxyspiro[1,3-benzodioxole-2,1'-cyclopentane]-4-yl)-2-phenylethenyl]pyridine Chemical compound C1=2OC3(CCCC3)OC=2C(OC)=CC=C1C(C=1C=CC=CC=1)=CC1=CC=NC=C1 XDFSBYSVMCFOGR-UHFFFAOYSA-N 0.000 description 1
- DVOYQBUJIBGUDZ-UHFFFAOYSA-N 4-[2-(7-methoxyspiro[3h-1-benzofuran-2,1'-cyclohexane]-4-yl)ethyl]pyridine Chemical compound C1=2CC3(CCCCC3)OC=2C(OC)=CC=C1CCC1=CC=NC=C1 DVOYQBUJIBGUDZ-UHFFFAOYSA-N 0.000 description 1
- RPLXINNRJIBFBT-UHFFFAOYSA-N 4-[2-(7-methoxyspiro[3h-1-benzofuran-2,1'-cyclopentane]-4-yl)ethyl]pyridine Chemical compound C1=2CC3(CCCC3)OC=2C(OC)=CC=C1CCC1=CC=NC=C1 RPLXINNRJIBFBT-UHFFFAOYSA-N 0.000 description 1
- UIWKYDZTMWIJGA-UHFFFAOYSA-N 4-[2-(8-methoxyspiro[3,4-dihydrochromene-2,1'-cyclohexane]-5-yl)ethenyl]pyridine Chemical compound C1=2CCC3(CCCCC3)OC=2C(OC)=CC=C1C=CC1=CC=NC=C1 UIWKYDZTMWIJGA-UHFFFAOYSA-N 0.000 description 1
- YETYPAMETFKUAL-UHFFFAOYSA-N 4-[7-methoxy-4-(1-phenyl-2-pyridin-4-ylethyl)-1-benzofuran-2-yl]pyridine Chemical compound C1=2C=C(C=3C=CN=CC=3)OC=2C(OC)=CC=C1C(C=1C=CC=CC=1)CC1=CC=NC=C1 YETYPAMETFKUAL-UHFFFAOYSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- WHSIIJQOEGXWSN-UHFFFAOYSA-N 4-bromo-2-methoxyphenol Chemical compound COC1=CC(Br)=CC=C1O WHSIIJQOEGXWSN-UHFFFAOYSA-N 0.000 description 1
- JROKHIJIUQPBMH-UHFFFAOYSA-N 4-bromo-7-methoxy-3-phenyl-1-benzofuran Chemical compound C=1OC=2C(OC)=CC=C(Br)C=2C=1C1=CC=CC=C1 JROKHIJIUQPBMH-UHFFFAOYSA-N 0.000 description 1
- DBUZWESZMNGRDG-UHFFFAOYSA-N 4-bromo-7-methoxyspiro[3h-1-benzofuran-2,1'-cyclopentane] Chemical compound O1C=2C(OC)=CC=C(Br)C=2CC21CCCC2 DBUZWESZMNGRDG-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 description 1
- 102000004008 5'-Nucleotidase Human genes 0.000 description 1
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 1
- NHKHFESSDRSYQR-UHFFFAOYSA-N 6-bromo-2-(cyclopent-2-en-1-ylmethyl)-3-methoxyphenol Chemical compound COC1=CC=C(Br)C(O)=C1CC1C=CCC1 NHKHFESSDRSYQR-UHFFFAOYSA-N 0.000 description 1
- LHDNAGKEKAUBNE-UHFFFAOYSA-N 7-bromo-4-methoxyspiro[3h-1-benzofuran-2,1'-cyclopentane] Chemical compound C1C=2C(OC)=CC=C(Br)C=2OC21CCCC2 LHDNAGKEKAUBNE-UHFFFAOYSA-N 0.000 description 1
- ZVPJQWBKNUJXSY-UHFFFAOYSA-N 7-methoxy-1-benzofuran-2-carbaldehyde Chemical compound COC1=CC=CC2=C1OC(C=O)=C2 ZVPJQWBKNUJXSY-UHFFFAOYSA-N 0.000 description 1
- HBBAARRYWZPLQU-UHFFFAOYSA-N 7-methoxy-2-pyridin-2-yl-1-benzofuran-4-carboxylic acid Chemical compound O1C=2C(OC)=CC=C(C(O)=O)C=2C=C1C1=CC=CC=N1 HBBAARRYWZPLQU-UHFFFAOYSA-N 0.000 description 1
- KELCBFOOTLOJSV-UHFFFAOYSA-N 7-methoxy-2-pyridin-4-yl-1-benzofuran-4-carbaldehyde Chemical compound O1C=2C(OC)=CC=C(C=O)C=2C=C1C1=CC=NC=C1 KELCBFOOTLOJSV-UHFFFAOYSA-N 0.000 description 1
- KFLTXSWJUCLJIU-UHFFFAOYSA-N 7-methoxy-2-pyridin-4-yl-1-benzofuran-4-carboxylic acid Chemical compound O1C=2C(OC)=CC=C(C(O)=O)C=2C=C1C1=CC=NC=C1 KFLTXSWJUCLJIU-UHFFFAOYSA-N 0.000 description 1
- LDQPCRKFWDSHPT-UHFFFAOYSA-N 7-methoxy-3-methyl-2,3-dihydro-1-benzofuran-4-carbaldehyde Chemical compound COC1=CC=C(C=O)C2=C1OCC2C LDQPCRKFWDSHPT-UHFFFAOYSA-N 0.000 description 1
- AIJAMWGKYDJMNA-UHFFFAOYSA-N 7-methoxy-3-methyl-2,3-dihydro-1-benzofuran-4-carboxylic acid Chemical compound COC1=CC=C(C(O)=O)C2=C1OCC2C AIJAMWGKYDJMNA-UHFFFAOYSA-N 0.000 description 1
- DIEGYYXJXJLEPB-UHFFFAOYSA-N 7-methoxy-3-phenyl-1-benzofuran-4-carboxylic acid Chemical compound C=1OC=2C(OC)=CC=C(C(O)=O)C=2C=1C1=CC=CC=C1 DIEGYYXJXJLEPB-UHFFFAOYSA-N 0.000 description 1
- WBBFJFNMHPUEKU-UHFFFAOYSA-N 7-methoxy-n,2-dipyridin-4-yl-1-benzofuran-4-carboxamide Chemical compound C1=2C=C(C=3C=CN=CC=3)OC=2C(OC)=CC=C1C(=O)NC1=CC=NC=C1 WBBFJFNMHPUEKU-UHFFFAOYSA-N 0.000 description 1
- PPGXKRBPWVJPEB-UHFFFAOYSA-N 7-methoxyspiro[1,3-benzodioxole-2,1'-cyclopentane]-4-carbaldehyde Chemical compound O1C=2C(OC)=CC=C(C=O)C=2OC21CCCC2 PPGXKRBPWVJPEB-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- KLHBAIKURAGONA-UHFFFAOYSA-N 8-methoxy-2,2-dimethyl-3,4-dihydrochromene-5-carboxylic acid Chemical compound C1CC(C)(C)OC2=C1C(C(O)=O)=CC=C2OC KLHBAIKURAGONA-UHFFFAOYSA-N 0.000 description 1
- ZKVFHYIMGRHRIP-UHFFFAOYSA-N 8-methoxy-2,2-dimethylchromene-5-carboxylic acid Chemical compound C1=CC(C)(C)OC2=C1C(C(O)=O)=CC=C2OC ZKVFHYIMGRHRIP-UHFFFAOYSA-N 0.000 description 1
- UAWNBFCFMSLPQV-UHFFFAOYSA-N 8-methoxyspiro[3,4-dihydrochromene-2,1'-cyclohexane]-4-ol Chemical compound O1C=2C(OC)=CC=CC=2C(O)CC21CCCCC2 UAWNBFCFMSLPQV-UHFFFAOYSA-N 0.000 description 1
- QQZJEGOIVSCCEH-UHFFFAOYSA-N 8-methoxyspiro[3,4-dihydrochromene-2,1'-cyclopentane]-4-ol Chemical compound O1C=2C(OC)=CC=CC=2C(O)CC21CCCC2 QQZJEGOIVSCCEH-UHFFFAOYSA-N 0.000 description 1
- HJGOFJFSEVDLGA-UHFFFAOYSA-N 8-methoxyspiro[chromene-2,1'-cyclopentane]-5-carbaldehyde Chemical compound O1C=2C(OC)=CC=C(C=O)C=2C=CC21CCCC2 HJGOFJFSEVDLGA-UHFFFAOYSA-N 0.000 description 1
- IRBAWVGZNJIROV-SFHVURJKSA-N 9-(2-cyclopropylethynyl)-2-[[(2s)-1,4-dioxan-2-yl]methoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C1=C2C3=CC=C(C#CC4CC4)C=C3CCN2C(=O)N=C1OC[C@@H]1COCCO1 IRBAWVGZNJIROV-SFHVURJKSA-N 0.000 description 1
- AEOBEOJCBAYXBA-UHFFFAOYSA-N A2P5P Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1OP(O)(O)=O AEOBEOJCBAYXBA-UHFFFAOYSA-N 0.000 description 1
- 102000016912 Aldehyde Reductase Human genes 0.000 description 1
- 108010053754 Aldehyde reductase Proteins 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- IYHHRZBKXXKDDY-UHFFFAOYSA-N BI-605906 Chemical compound N=1C=2SC(C(N)=O)=C(N)C=2C(C(F)(F)CC)=CC=1N1CCC(S(C)(=O)=O)CC1 IYHHRZBKXXKDDY-UHFFFAOYSA-N 0.000 description 1
- KYNSBQPICQTCGU-UHFFFAOYSA-N Benzopyrane Chemical compound C1=CC=C2C=CCOC2=C1 KYNSBQPICQTCGU-UHFFFAOYSA-N 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 208000009079 Bronchial Spasm Diseases 0.000 description 1
- 208000014181 Bronchial disease Diseases 0.000 description 1
- UHNRLQRZRNKOKU-UHFFFAOYSA-N CCN(CC1=NC2=C(N1)C1=CC=C(C=C1N=C2N)C1=NNC=C1)C(C)=O Chemical compound CCN(CC1=NC2=C(N1)C1=CC=C(C=C1N=C2N)C1=NNC=C1)C(C)=O UHNRLQRZRNKOKU-UHFFFAOYSA-N 0.000 description 1
- 101150041968 CDC13 gene Proteins 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
- PMPVIKIVABFJJI-UHFFFAOYSA-N Cyclobutane Chemical compound C1CCC1 PMPVIKIVABFJJI-UHFFFAOYSA-N 0.000 description 1
- LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical compound C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 229910002604 Ga-H Inorganic materials 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000003746 Insulin Receptor Human genes 0.000 description 1
- 108010001127 Insulin Receptor Proteins 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- YEWGIGCYIAMFMA-UHFFFAOYSA-N LSM-2007 Chemical compound C1C2=CC=CC=C2CCN(C)CCC2=C1NC1=CC=CC=C21 YEWGIGCYIAMFMA-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 240000000233 Melia azedarach Species 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 229940124639 Selective inhibitor Drugs 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 102000003141 Tachykinin Human genes 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- 229940122618 Trypsin inhibitor Drugs 0.000 description 1
- 101710162629 Trypsin inhibitor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 101100020289 Xenopus laevis koza gene Proteins 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- WGZCUXZFISUUPR-UHFFFAOYSA-N acetonitrile;oxolane Chemical compound CC#N.C1CCOC1 WGZCUXZFISUUPR-UHFFFAOYSA-N 0.000 description 1
- 102000005421 acetyltransferase Human genes 0.000 description 1
- 108020002494 acetyltransferase Proteins 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- YKIOKAURTKXMSB-UHFFFAOYSA-N adams's catalyst Chemical compound O=[Pt]=O YKIOKAURTKXMSB-UHFFFAOYSA-N 0.000 description 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000003927 aminopyridines Chemical class 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 229940124339 anthelmintic agent Drugs 0.000 description 1
- 239000000921 anthelmintic agent Substances 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 description 1
- 150000005528 benzodioxoles Chemical class 0.000 description 1
- 150000001562 benzopyrans Chemical class 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- IBUKBIYLTPOVRB-UHFFFAOYSA-N benzyl 2-[4-[(7-methoxy-2,3-dihydro-1-benzofuran-2-carbonyl)amino]pyridin-3-yl]acetate Chemical compound C(C1=CC=CC=C1)OC(=O)CC=1C=NC=CC=1NC(=O)C1OC2=C(C1)C=CC=C2OC IBUKBIYLTPOVRB-UHFFFAOYSA-N 0.000 description 1
- BQOZBXKPLHYQNT-UHFFFAOYSA-N benzyl 2-[7-methoxy-4-(phenylcarbamoyl)-2,3-dihydro-1-benzofuran-3-yl]acetate Chemical compound C1=2C(CC(=O)OCC=3C=CC=CC=3)COC=2C(OC)=CC=C1C(=O)NC1=CC=CC=C1 BQOZBXKPLHYQNT-UHFFFAOYSA-N 0.000 description 1
- OXHWWVIGQIMDMH-UHFFFAOYSA-N benzyl 4-(cyclohexylcarbamoyl)-7-methoxy-2,3-dihydro-1-benzofuran-3-carboxylate Chemical compound C1=2C(C(=O)OCC=3C=CC=CC=3)COC=2C(OC)=CC=C1C(=O)NC1CCCCC1 OXHWWVIGQIMDMH-UHFFFAOYSA-N 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- ODWXUNBKCRECNW-UHFFFAOYSA-M bromocopper(1+) Chemical compound Br[Cu+] ODWXUNBKCRECNW-UHFFFAOYSA-M 0.000 description 1
- 239000004044 bronchoconstricting agent Substances 0.000 description 1
- 230000003435 bronchoconstrictive effect Effects 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- JJNHBFYGCSOONU-UHFFFAOYSA-M carbanide;cyclopenta-1,3-diene;dimethylaluminum;titanium(4+);chloride Chemical compound [CH3-].[Ti+3]Cl.C[Al]C.C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 JJNHBFYGCSOONU-UHFFFAOYSA-M 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical group OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- OQNGCCWBHLEQFN-UHFFFAOYSA-N chloroform;hexane Chemical compound ClC(Cl)Cl.CCCCCC OQNGCCWBHLEQFN-UHFFFAOYSA-N 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940125810 compound 20 Drugs 0.000 description 1
- LMGZGXSXHCMSAA-UHFFFAOYSA-N cyclodecane Chemical compound C1CCCCCCCCC1 LMGZGXSXHCMSAA-UHFFFAOYSA-N 0.000 description 1
- PQANGXXSEABURG-UHFFFAOYSA-N cyclohex-2-en-1-ol Chemical compound OC1CCCC=C1 PQANGXXSEABURG-UHFFFAOYSA-N 0.000 description 1
- GPTJTTCOVDDHER-UHFFFAOYSA-N cyclononane Chemical compound C1CCCCCCCC1 GPTJTTCOVDDHER-UHFFFAOYSA-N 0.000 description 1
- WJTCGQSWYFHTAC-UHFFFAOYSA-N cyclooctane Chemical compound C1CCCCCCC1 WJTCGQSWYFHTAC-UHFFFAOYSA-N 0.000 description 1
- 239000004914 cyclooctane Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- GRTGGSXWHGKRSB-UHFFFAOYSA-N dichloromethyl methyl ether Chemical compound COC(Cl)Cl GRTGGSXWHGKRSB-UHFFFAOYSA-N 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 1
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- OIKHZBFJHONJJB-UHFFFAOYSA-N dimethyl(phenyl)silicon Chemical compound C[Si](C)C1=CC=CC=C1 OIKHZBFJHONJJB-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- DZGCGKFAPXFTNM-UHFFFAOYSA-N ethanol;hydron;chloride Chemical compound Cl.CCO DZGCGKFAPXFTNM-UHFFFAOYSA-N 0.000 description 1
- YFQXZAHBTNRMJY-FOWTUZBSSA-N ethyl (e)-3-(7-methoxy-2,2-dimethyl-3h-1-benzofuran-4-yl)-2-pyridin-4-ylprop-2-enoate Chemical compound C=1C=C(OC)C=2OC(C)(C)CC=2C=1/C=C(C(=O)OCC)\C1=CC=NC=C1 YFQXZAHBTNRMJY-FOWTUZBSSA-N 0.000 description 1
- NGZPQZJCFNQBPZ-SNAWJCMRSA-N ethyl (e)-4-(3-formyl-2-iodo-6-methoxyphenoxy)but-2-enoate Chemical compound CCOC(=O)\C=C\COC1=C(I)C(C=O)=CC=C1OC NGZPQZJCFNQBPZ-SNAWJCMRSA-N 0.000 description 1
- YHGVZVYRHWZVKI-HYXAFXHYSA-N ethyl (z)-2-bromobut-2-enoate Chemical compound CCOC(=O)C(\Br)=C\C YHGVZVYRHWZVKI-HYXAFXHYSA-N 0.000 description 1
- OUWWGJRQXFGUIW-UHFFFAOYSA-N ethyl 2-[4-[(3,5-dichloropyridin-4-yl)carbamoyl]-7-methoxy-2,3-dihydro-1-benzofuran-3-yl]acetate Chemical compound CCOC(=O)CC1COC(C(=CC=2)OC)=C1C=2C(=O)NC1=C(Cl)C=NC=C1Cl OUWWGJRQXFGUIW-UHFFFAOYSA-N 0.000 description 1
- PBOQLOPCDQCCGM-UHFFFAOYSA-N ethyl 2-[4-[(7-methoxy-2,3-dihydro-1-benzofuran-2-carbonyl)amino]pyridin-3-yl]acetate Chemical compound C(C)OC(=O)CC=1C=NC=CC=1NC(=O)C1OC2=C(C1)C=CC=C2OC PBOQLOPCDQCCGM-UHFFFAOYSA-N 0.000 description 1
- HCQMGLWAFPFKOK-UHFFFAOYSA-N ethyl 2-cyano-3-(7-methoxy-2,2-dimethyl-3h-1-benzofuran-4-yl)prop-2-enoate Chemical compound CCOC(=O)C(C#N)=CC1=CC=C(OC)C2=C1CC(C)(C)O2 HCQMGLWAFPFKOK-UHFFFAOYSA-N 0.000 description 1
- ZIUSEGSNTOUIPT-UHFFFAOYSA-N ethyl 2-cyanoacetate Chemical compound CCOC(=O)CC#N ZIUSEGSNTOUIPT-UHFFFAOYSA-N 0.000 description 1
- GWNFQAKCJYEJEW-UHFFFAOYSA-N ethyl 3-[8-[[4-methyl-5-[(3-methyl-4-oxophthalazin-1-yl)methyl]-1,2,4-triazol-3-yl]sulfanyl]octanoylamino]benzoate Chemical compound CCOC(=O)C1=CC(NC(=O)CCCCCCCSC2=NN=C(CC3=NN(C)C(=O)C4=CC=CC=C34)N2C)=CC=C1 GWNFQAKCJYEJEW-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- ICLWTJIMXVISSR-UHFFFAOYSA-N gallamine Chemical compound CCN(CC)CCOC1=CC=CC(OCCN(CC)CC)=C1OCCN(CC)CC ICLWTJIMXVISSR-UHFFFAOYSA-N 0.000 description 1
- 229960003054 gallamine Drugs 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 1
- 229940029575 guanosine Drugs 0.000 description 1
- 239000004312 hexamethylene tetramine Substances 0.000 description 1
- 235000010299 hexamethylene tetramine Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 150000004694 iodide salts Chemical class 0.000 description 1
- 208000023589 ischemic disease Diseases 0.000 description 1
- CFHGBZLNZZVTAY-UHFFFAOYSA-N lawesson's reagent Chemical compound C1=CC(OC)=CC=C1P1(=S)SP(=S)(C=2C=CC(OC)=CC=2)S1 CFHGBZLNZZVTAY-UHFFFAOYSA-N 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- LULAYUGMBFYYEX-UHFFFAOYSA-N metachloroperbenzoic acid Natural products OC(=O)C1=CC=CC(Cl)=C1 LULAYUGMBFYYEX-UHFFFAOYSA-N 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- RPNNPZHFJPXFQS-UHFFFAOYSA-N methane;rhodium Chemical compound C.[Rh] RPNNPZHFJPXFQS-UHFFFAOYSA-N 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- HAALPWFBPFLZLZ-GXSJLCMTSA-N methyl (5ar,9ar)-4-methoxy-5a,6,7,8,9,9a-hexahydrodibenzofuran-1-carboxylate Chemical compound C([C@H]1O2)CCC[C@@H]1C1=C2C(OC)=CC=C1C(=O)OC HAALPWFBPFLZLZ-GXSJLCMTSA-N 0.000 description 1
- XBBBHBXXAJKNGM-UHFFFAOYSA-N methyl 2-(2-ethylphenyl)-7-methoxy-1-benzofuran-4-carboxylate Chemical compound CCC1=CC=CC=C1C1=CC2=C(C(=O)OC)C=CC(OC)=C2O1 XBBBHBXXAJKNGM-UHFFFAOYSA-N 0.000 description 1
- SUSJTIGRSLOAPC-UHFFFAOYSA-N methyl 2-(cyclohex-2-en-1-ylmethyl)-3-hydroxy-4-methoxybenzoate Chemical compound COC(=O)C1=CC=C(OC)C(O)=C1CC1C=CCCC1 SUSJTIGRSLOAPC-UHFFFAOYSA-N 0.000 description 1
- XKUBTZUYKLTYRF-UHFFFAOYSA-N methyl 2-benzyl-7-methoxy-1-benzofuran-4-carboxylate Chemical compound C=1C=2C(C(=O)OC)=CC=C(OC)C=2OC=1CC1=CC=CC=C1 XKUBTZUYKLTYRF-UHFFFAOYSA-N 0.000 description 1
- VTFXKCZOMBEHDT-UHFFFAOYSA-N methyl 2-butyl-7-methoxy-1-benzofuran-4-carboxylate Chemical compound C1=CC(OC)=C2OC(CCCC)=CC2=C1C(=O)OC VTFXKCZOMBEHDT-UHFFFAOYSA-N 0.000 description 1
- VZDNXXPBYLGWOS-UHFFFAOYSA-N methyl 3-aminobenzoate Chemical compound COC(=O)C1=CC=CC(N)=C1 VZDNXXPBYLGWOS-UHFFFAOYSA-N 0.000 description 1
- FOYGLHPVGVDCJZ-UHFFFAOYSA-N methyl 4-methoxyspiro[3h-1-benzofuran-2,1'-cyclopentane]-7-carboxylate Chemical compound O1C=2C(C(=O)OC)=CC=C(OC)C=2CC21CCCC2 FOYGLHPVGVDCJZ-UHFFFAOYSA-N 0.000 description 1
- MCHBQLISEXWKLW-UHFFFAOYSA-N methyl 7-methoxy-3-phenyl-1-benzofuran-4-carboxylate Chemical compound C1=2C(C(=O)OC)=CC=C(OC)C=2OC=C1C1=CC=CC=C1 MCHBQLISEXWKLW-UHFFFAOYSA-N 0.000 description 1
- YAZSLOLRWJFRQL-UHFFFAOYSA-N methyl 8-methoxy-2,2-dimethyl-3,4-dihydrochromene-5-carboxylate Chemical compound O1C(C)(C)CCC2=C1C(OC)=CC=C2C(=O)OC YAZSLOLRWJFRQL-UHFFFAOYSA-N 0.000 description 1
- JAGNTHOFULRQIS-UHFFFAOYSA-N methyl 8-methoxy-2,2-dimethylchromene-5-carboxylate Chemical compound O1C(C)(C)C=CC2=C1C(OC)=CC=C2C(=O)OC JAGNTHOFULRQIS-UHFFFAOYSA-N 0.000 description 1
- NBVOUXRYPLHHTJ-UHFFFAOYSA-N methyl 8-methoxyspiro[3,4-dihydrochromene-2,1'-cyclohexane]-5-carboxylate Chemical compound C1CC=2C(C(=O)OC)=CC=C(OC)C=2OC21CCCCC2 NBVOUXRYPLHHTJ-UHFFFAOYSA-N 0.000 description 1
- DLLNFRROQPZDCV-UHFFFAOYSA-N methyl 8-methoxyspiro[chromene-2,1'-cyclohexane]-5-carboxylate Chemical compound C1=CC=2C(C(=O)OC)=CC=C(OC)C=2OC21CCCCC2 DLLNFRROQPZDCV-UHFFFAOYSA-N 0.000 description 1
- XMJNDHDHHLEBHE-UHFFFAOYSA-N methyl 8-methoxyspiro[chromene-2,1'-cyclopentane]-5-carboxylate Chemical compound C1=CC=2C(C(=O)OC)=CC=C(OC)C=2OC21CCCC2 XMJNDHDHHLEBHE-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
- WWECJGLXBSQKRF-UHFFFAOYSA-N n,n-dimethylformamide;methanol Chemical compound OC.CN(C)C=O WWECJGLXBSQKRF-UHFFFAOYSA-N 0.000 description 1
- ZPGANYIABRHXJR-UHFFFAOYSA-N n-(3,5-dichloropyridin-4-yl)-3-[2-[(3,5-dichloropyridin-4-yl)amino]-2-oxoethyl]-7-methoxy-2,3-dihydro-1-benzofuran-4-carboxamide Chemical compound C1=2C(CC(=O)NC=3C(=CN=CC=3Cl)Cl)COC=2C(OC)=CC=C1C(=O)NC1=C(Cl)C=NC=C1Cl ZPGANYIABRHXJR-UHFFFAOYSA-N 0.000 description 1
- HUNUDGFJDFFHID-UHFFFAOYSA-N n-(3,5-dichloropyridin-4-yl)-3-ethyl-7-methoxy-2,3-dihydro-1-benzofuran-4-carboxamide Chemical compound CCC1COC(C(=CC=2)OC)=C1C=2C(=O)NC1=C(Cl)C=NC=C1Cl HUNUDGFJDFFHID-UHFFFAOYSA-N 0.000 description 1
- IJOCDYMFIRKGJK-UHFFFAOYSA-N n-(3,5-dichloropyridin-4-yl)-7-methoxy-1-benzofuran-4-carboxamide Chemical compound C1=2C=COC=2C(OC)=CC=C1C(=O)NC1=C(Cl)C=NC=C1Cl IJOCDYMFIRKGJK-UHFFFAOYSA-N 0.000 description 1
- VYBYFHPHHSYOLH-UHFFFAOYSA-N n-(3,5-dichloropyridin-4-yl)-7-methoxy-2-methyl-3-(1,2,3,4-tetrahydroisoquinoline-1-carbonyl)-2,3-dihydro-1-benzofuran-4-carboxamide Chemical compound C1=2C(C(=O)C3C4=CC=CC=C4CCN3)C(C)OC=2C(OC)=CC=C1C(=O)NC1=C(Cl)C=NC=C1Cl VYBYFHPHHSYOLH-UHFFFAOYSA-N 0.000 description 1
- FRTVVERWDKARQQ-UHFFFAOYSA-N n-(3,5-dichloropyridin-4-yl)-7-methoxy-2-pyridin-2-yl-1-benzofuran-4-carboxamide Chemical compound C1=2C=C(C=3N=CC=CC=3)OC=2C(OC)=CC=C1C(=O)NC1=C(Cl)C=NC=C1Cl FRTVVERWDKARQQ-UHFFFAOYSA-N 0.000 description 1
- QRLVPRRVXWRUQN-UHFFFAOYSA-N n-(3,5-dichloropyridin-4-yl)-7-methoxy-2-pyridin-4-yl-1-benzofuran-4-carboxamide Chemical compound C1=2C=C(C=3C=CN=CC=3)OC=2C(OC)=CC=C1C(=O)NC1=C(Cl)C=NC=C1Cl QRLVPRRVXWRUQN-UHFFFAOYSA-N 0.000 description 1
- RDDRBSCKIVSJDU-UHFFFAOYSA-N n-(3,5-dichloropyridin-4-yl)-7-methoxy-3-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-2,3-dihydro-1-benzofuran-4-carboxamide Chemical compound C1=2C(CC(=O)N3CCN(C)CC3)COC=2C(OC)=CC=C1C(=O)NC1=C(Cl)C=NC=C1Cl RDDRBSCKIVSJDU-UHFFFAOYSA-N 0.000 description 1
- JMARLRBQRWIVSI-UHFFFAOYSA-N n-(3,5-dichloropyridin-4-yl)-7-methoxy-3-[2-oxo-2-(pyridin-2-ylmethylamino)ethyl]-2,3-dihydro-1-benzofuran-4-carboxamide Chemical compound C1=2C(CC(=O)NCC=3N=CC=CC=3)COC=2C(OC)=CC=C1C(=O)NC1=C(Cl)C=NC=C1Cl JMARLRBQRWIVSI-UHFFFAOYSA-N 0.000 description 1
- NIPKLBWGSACZLK-UHFFFAOYSA-N n-(3,5-dichloropyridin-4-yl)-7-methoxy-3-[2-oxo-2-(pyridin-3-ylamino)ethyl]-2,3-dihydro-1-benzofuran-4-carboxamide Chemical compound C1=2C(CC(=O)NC=3C=NC=CC=3)COC=2C(OC)=CC=C1C(=O)NC1=C(Cl)C=NC=C1Cl NIPKLBWGSACZLK-UHFFFAOYSA-N 0.000 description 1
- JZIVKAQTYRVWBU-UHFFFAOYSA-N n-(3,5-dichloropyridin-4-yl)-7-methoxy-3-[2-oxo-2-(pyridin-3-ylmethylamino)ethyl]-2,3-dihydro-1-benzofuran-4-carboxamide Chemical compound C1=2C(CC(=O)NCC=3C=NC=CC=3)COC=2C(OC)=CC=C1C(=O)NC1=C(Cl)C=NC=C1Cl JZIVKAQTYRVWBU-UHFFFAOYSA-N 0.000 description 1
- TUWFLTAVVGQTQZ-UHFFFAOYSA-N n-(3,5-dichloropyridin-4-yl)-7-methoxy-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-2,3-dihydro-1-benzofuran-4-carboxamide Chemical compound C1=2C(CC(=O)NCC=3C=CN=CC=3)COC=2C(OC)=CC=C1C(=O)NC1=C(Cl)C=NC=C1Cl TUWFLTAVVGQTQZ-UHFFFAOYSA-N 0.000 description 1
- PPBVCLGXCHVIOU-UHFFFAOYSA-N n-(3,5-dichloropyridin-4-yl)-7-methoxy-3-[2-oxo-2-(pyrimidin-2-ylamino)ethyl]-2,3-dihydro-1-benzofuran-4-carboxamide Chemical compound C1=2C(CC(=O)NC=3N=CC=CN=3)COC=2C(OC)=CC=C1C(=O)NC1=C(Cl)C=NC=C1Cl PPBVCLGXCHVIOU-UHFFFAOYSA-N 0.000 description 1
- QCKJCHWUWWQZMP-UHFFFAOYSA-N n-(3,5-dichloropyridin-4-yl)-7-methoxy-3-phenyl-1-benzofuran-4-carboxamide Chemical compound C1=2C(C=3C=CC=CC=3)=COC=2C(OC)=CC=C1C(=O)NC1=C(Cl)C=NC=C1Cl QCKJCHWUWWQZMP-UHFFFAOYSA-N 0.000 description 1
- QSVYCCGWISVICA-UHFFFAOYSA-N n-(3,5-dichloropyridin-4-yl)-8-methoxy-2,2-dimethyl-3,4-dihydrochromene-5-carboxamide Chemical compound C1=2CCC(C)(C)OC=2C(OC)=CC=C1C(=O)NC1=C(Cl)C=NC=C1Cl QSVYCCGWISVICA-UHFFFAOYSA-N 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- KGCNHWXDPDPSBV-UHFFFAOYSA-N p-nitrobenzyl chloride Chemical compound [O-][N+](=O)C1=CC=C(CCl)C=C1 KGCNHWXDPDPSBV-UHFFFAOYSA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 1
- LIGACIXOYTUXAW-UHFFFAOYSA-N phenacyl bromide Chemical compound BrCC(=O)C1=CC=CC=C1 LIGACIXOYTUXAW-UHFFFAOYSA-N 0.000 description 1
- IMACFCSSMIZSPP-UHFFFAOYSA-N phenacyl chloride Chemical compound ClCC(=O)C1=CC=CC=C1 IMACFCSSMIZSPP-UHFFFAOYSA-N 0.000 description 1
- YZTJYBJCZXZGCT-UHFFFAOYSA-N phenylpiperazine Chemical compound C1CNCCN1C1=CC=CC=C1 YZTJYBJCZXZGCT-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- ACVYVLVWPXVTIT-UHFFFAOYSA-N phosphinic acid Chemical compound O[PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-N 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- CYQAYERJWZKYML-UHFFFAOYSA-N phosphorus pentasulfide Chemical compound S1P(S2)(=S)SP3(=S)SP1(=S)SP2(=S)S3 CYQAYERJWZKYML-UHFFFAOYSA-N 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 108010043671 prostatic acid phosphatase Proteins 0.000 description 1
- HDOUGSFASVGDCS-UHFFFAOYSA-N pyridin-3-ylmethanamine Chemical compound NCC1=CC=CN=C1 HDOUGSFASVGDCS-UHFFFAOYSA-N 0.000 description 1
- TXQWFIVRZNOPCK-UHFFFAOYSA-N pyridin-4-ylmethanamine Chemical compound NCC1=CC=NC=C1 TXQWFIVRZNOPCK-UHFFFAOYSA-N 0.000 description 1
- JQRYUMGHOUYJFW-UHFFFAOYSA-N pyridine;trihydrobromide Chemical compound [Br-].[Br-].[Br-].C1=CC=[NH+]C=C1.C1=CC=[NH+]C=C1.C1=CC=[NH+]C=C1 JQRYUMGHOUYJFW-UHFFFAOYSA-N 0.000 description 1
- LJXQPZWIHJMPQQ-UHFFFAOYSA-N pyrimidin-2-amine Chemical compound NC1=NC=CC=N1 LJXQPZWIHJMPQQ-UHFFFAOYSA-N 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000001533 respiratory mucosa Anatomy 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical compound [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 description 1
- 229960002218 sodium chlorite Drugs 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 108060008037 tachykinin Proteins 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- SFLXUZPXEWWQNH-UHFFFAOYSA-K tetrabutylazanium;tribromide Chemical compound [Br-].[Br-].[Br-].CCCC[N+](CCCC)(CCCC)CCCC.CCCC[N+](CCCC)(CCCC)CCCC.CCCC[N+](CCCC)(CCCC)CCCC SFLXUZPXEWWQNH-UHFFFAOYSA-K 0.000 description 1
- QEMXHQIAXOOASZ-UHFFFAOYSA-N tetramethylammonium Chemical compound C[N+](C)(C)C QEMXHQIAXOOASZ-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- ISEIIPDWJVGTQS-UHFFFAOYSA-N tributylsilicon Chemical compound CCCC[Si](CCCC)CCCC ISEIIPDWJVGTQS-UHFFFAOYSA-N 0.000 description 1
- ZDHXKXAHOVTTAH-UHFFFAOYSA-N trichlorosilane Chemical compound Cl[SiH](Cl)Cl ZDHXKXAHOVTTAH-UHFFFAOYSA-N 0.000 description 1
- 239000005052 trichlorosilane Substances 0.000 description 1
- GGUBFICZYGKNTD-UHFFFAOYSA-N triethyl phosphonoacetate Chemical compound CCOC(=O)CP(=O)(OCC)OCC GGUBFICZYGKNTD-UHFFFAOYSA-N 0.000 description 1
- LEIMLDGFXIOXMT-UHFFFAOYSA-N trimethylsilyl cyanide Chemical compound C[Si](C)(C)C#N LEIMLDGFXIOXMT-UHFFFAOYSA-N 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12153795 | 1995-05-19 | ||
JP25865195 | 1995-10-05 | ||
PCT/JP1996/001327 WO1996036624A1 (fr) | 1995-05-19 | 1996-05-20 | Composes heterocycliques contenant de l'oxygene |
Publications (3)
Publication Number | Publication Date |
---|---|
NO970151D0 NO970151D0 (no) | 1997-01-14 |
NO970151L NO970151L (no) | 1997-03-06 |
NO317631B1 true NO317631B1 (no) | 2004-11-29 |
Family
ID=26458881
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19970151A NO317631B1 (no) | 1995-05-19 | 1997-01-14 | Oksygeninneholdende heterocykliske forbindelser |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0771794B1 (ko) |
JP (1) | JP4172817B2 (ko) |
KR (1) | KR100445356B1 (ko) |
CN (1) | CN1163493C (ko) |
AT (1) | ATE325110T1 (ko) |
AU (1) | AU705690B2 (ko) |
CA (1) | CA2195755A1 (ko) |
DE (1) | DE69636086T2 (ko) |
DK (1) | DK0771794T3 (ko) |
ES (1) | ES2258775T3 (ko) |
HK (1) | HK1000785A1 (ko) |
NO (1) | NO317631B1 (ko) |
PT (1) | PT771794E (ko) |
WO (1) | WO1996036624A1 (ko) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996036626A1 (de) * | 1995-05-18 | 1996-11-21 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Cyclohexyldihydrobenzofurane |
ATE231501T1 (de) * | 1995-05-18 | 2003-02-15 | Altana Pharma Ag | Phenyldihydrobenzofurane |
JP2000501411A (ja) * | 1995-12-05 | 2000-02-08 | ダーウィン・ディスカバリー・リミテッド | ベンゾフランカルボキサミドおよびスルホンアミド |
IL126558A (en) * | 1996-05-20 | 2002-07-25 | Darwin Discovery Ltd | Benzofuran carboxamides and pharmaceutical compositions containing them |
DE69717827T2 (de) * | 1996-08-19 | 2003-09-04 | Altana Pharma Ag | Benzofuran-4-carboxamide |
WO1998022455A1 (fr) * | 1996-11-19 | 1998-05-28 | Kyowa Hakko Kogyo Co., Ltd. | Composes heterocycliques d'oxygene |
WO1999016768A1 (en) * | 1997-10-01 | 1999-04-08 | Kyowa Hakko Kogyo Co., Ltd. | Benzofuran derivatives |
CA2317478A1 (en) * | 1998-02-09 | 1999-08-12 | Darwin Discovery Limited | Benzofuran-4-carboxamides and their therapeutic use |
ATE263166T1 (de) * | 1998-07-06 | 2004-04-15 | Altana Pharma Ag | Neue benzoxazole mit pde-hemmender wirkung |
EA004138B1 (ru) | 1998-09-03 | 2004-02-26 | Киова Хакко Когио Ко., Лтд. | ПРОИЗВОДНЫЕ БЕНЗО(b)ЦИКЛОДИОКСААЛКАНА |
AU781577B2 (en) * | 1998-12-30 | 2005-06-02 | Lakewood-Amedex, Inc. | Therapeutic phosphodiesterase inhibitors |
AU6315300A (en) * | 1999-07-26 | 2001-02-13 | Shionogi & Co., Ltd. | Benzene derivatives and immunopotentiating compositions or drug-sensitivity restoring agents containing the same |
WO2003000697A1 (fr) * | 2001-06-22 | 2003-01-03 | Takeda Chemical Industries, Ltd. | Derive de furo-isoquinoline, procede de production de ce compose et utilisation de ce compose |
DE10205274A1 (de) * | 2002-02-08 | 2003-08-21 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen enthaltend neben Anticholinergika heterocyclische Verbindungen |
DE10216427A1 (de) * | 2002-04-12 | 2003-10-23 | Boehringer Ingelheim Pharma | Arzneimittelkompositionen enthaltend heterocyclische Verbindungen und ein neues Anticholinergikum |
AU2003252467A1 (en) * | 2002-07-03 | 2004-01-23 | Kyowa Hakko Kogyo Co., Ltd. | Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives |
RU2005131943A (ru) * | 2003-03-17 | 2006-03-20 | Киова Хакко Когио Ко., Лтд. (Jp) | Лечебные и/или профилактические средства для хронических болезней кожи |
WO2004087150A1 (ja) * | 2003-03-31 | 2004-10-14 | Kyowa Hakko Kogyo Co. Ltd. | 医薬組成物 |
JPWO2004087146A1 (ja) * | 2003-03-31 | 2006-06-29 | 協和醗酵工業株式会社 | 微粒子混合物の製造方法 |
TW200420554A (en) * | 2003-03-31 | 2004-10-16 | Kyowa Hakko Kogyo Kk | A intra-airway administrating preparation |
US20060199789A1 (en) * | 2003-03-31 | 2006-09-07 | Kyowa Hakko Kogyo Co., Ltd. | medical composition |
WO2004087151A1 (ja) * | 2003-03-31 | 2004-10-14 | Kyowa Hakko Kogyo Co., Ltd. | 医薬組成物 |
JPWO2004087148A1 (ja) * | 2003-03-31 | 2006-06-29 | 協和醗酵工業株式会社 | 肺疾患の治療および/または予防剤 |
WO2004087147A1 (ja) * | 2003-03-31 | 2004-10-14 | Kyowa Hakko Kogyo Co., Ltd. | 肺疾患の治療および/または予防剤 |
JPWO2004112791A1 (ja) * | 2003-06-23 | 2006-07-27 | 協和醗酵工業株式会社 | 肺疾患の治療および/または予防剤 |
EP1504756A1 (en) * | 2003-08-06 | 2005-02-09 | Kyowa Hakko Kogyo Co., Ltd | Medicament compositions comprising a heterocyclic compound and an anticholinergic |
WO2006041121A1 (ja) * | 2004-10-13 | 2006-04-20 | Kyowa Hakko Kogyo Co., Ltd. | 慢性皮膚疾患の治療および/または予防剤 |
US20080085858A1 (en) * | 2004-10-13 | 2008-04-10 | Kyowa Hakko Kogyo Co., Ltd. | Pharmaceutical Composition |
WO2006123726A1 (ja) * | 2005-05-18 | 2006-11-23 | Kyowa Hakko Kogyo Co., Ltd. | 医薬組成物 |
US20100056791A1 (en) * | 2006-09-01 | 2010-03-04 | Yasushi Kohno | Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor containing the same |
US20090318385A1 (en) * | 2006-09-06 | 2009-12-24 | Yasushi Kohno | Pyrazolopyride derivative and phosphodiesterase ( pde) inhibitors containing the same as active ingredient |
BRPI0721113A2 (pt) * | 2006-12-22 | 2014-10-07 | Leo Pharma As | Composto, composição farmacêutica, uso de um composto, e, método para prevenir, tratar ou melhorar doenças ou condições dérmicas ou distúrbios |
MY150075A (en) | 2007-02-28 | 2013-11-29 | Leo Pharma As | Novel phosphodiesterase inhibitors |
EP2146989B1 (en) | 2007-04-16 | 2012-01-04 | Leo Pharma A/S | Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases |
SI2379548T1 (sl) | 2008-12-19 | 2016-06-30 | Leo Pharma A/S | Triazolopiridini kot fosfodiesterazni inhibitorji za zdravljenje kožnih bolezni |
HUE044301T2 (hu) | 2010-06-24 | 2019-10-28 | Leo Pharma As | Benzodioxol-származékok, mint foszfodiészteráz inhibitorok |
WO2013092739A1 (en) | 2011-12-21 | 2013-06-27 | Leo Pharma A/S | [1,2,4]triazolopyridines and their use as phospodiesterase inhibitors |
TW201613934A (en) * | 2014-06-23 | 2016-04-16 | Leo Pharma As | Methods for the preparation of 1,3-benzodioxole heterocyclic compounds |
CN106588841B (zh) * | 2015-10-19 | 2019-01-25 | 富乐马鸿凯(大连)医药有限公司 | 合成2,3-二氢-1-苯并呋喃-4-甲醛的方法 |
CN106588900A (zh) * | 2015-10-20 | 2017-04-26 | 北京康辰医药科技有限公司 | 一种苯并双环化合物或其药学上可接受的盐、药物组合物及其应用 |
CN106905336B (zh) * | 2017-01-22 | 2019-04-09 | 浙江工业大学 | 一种手性吡唑螺呋喃类化合物的不对称合成方法 |
CN107325067B (zh) * | 2017-05-03 | 2020-05-12 | 广州中医药大学 | 磷酸二酯酶4抑制剂桑辛素m衍生物及其用途 |
IL271399B (en) | 2017-06-20 | 2022-07-01 | Leo Pharma As | Methods for the preparation of heterocyclic 3,1-benzodioxole compounds |
CN109721579B (zh) * | 2017-10-27 | 2022-11-04 | 中国医学科学院药物研究所 | 7,8-脱氢葡萄藤戊素衍生物、其制法和药物组合物与用途 |
CN109721580B (zh) * | 2017-10-27 | 2022-11-04 | 中国医学科学院药物研究所 | 3-苯基-7,8-脱氢葡萄藤戊素衍生物、其制法和药物组合物与用途 |
CN114478413B (zh) * | 2022-01-14 | 2023-06-23 | 北京富盛嘉华医药科技有限公司 | 2-(2′-羟基-3′-甲代烯丙基-5′-甲基苯基)苯并三氮唑的制备方法及应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2507604A2 (fr) * | 1977-04-19 | 1982-12-17 | Delalande Sa | Nouvelles trimethoxy-3,4,5 cinnamoyle piperazines, leur procede de preparation et leur application en therapeutique |
CA1297877C (en) * | 1983-12-22 | 1992-03-24 | Daniel Lednicer | Benzofurancarboxamides useful as antiemetic or antipsychotic agents |
JPS62234083A (ja) * | 1986-02-28 | 1987-10-14 | アーバモント インク ディビーエイ アドリヤ ラボラトリーズ | 鎮吐薬または精神病治療薬として有用なカルボキサミド類 |
JPH01207267A (ja) * | 1987-03-05 | 1989-08-21 | Yamanouchi Pharmaceut Co Ltd | ピリジン誘導体及び該化合物を含有する肝疾患治療剤 |
IL87674A (en) * | 1987-09-08 | 1993-08-18 | Lilly Co Eli | Azabicycloalkyl esters and amides of heterocyclic acids, their preparation and pharmaceutical compositions containing them |
US5366986A (en) * | 1988-04-15 | 1994-11-22 | T Cell Sciences, Inc. | Compounds which inhibit complement and/or suppress immune activity |
CA2114114C (en) * | 1992-06-15 | 2005-05-03 | Nigel Robert Arnold Beeley | Trisubstituted phenyl derivatives as selective phosphodiesterase iv inhibitors |
MX9700557A (es) * | 1994-07-22 | 1997-12-31 | Byk Gulden Lomberg Chem Fab | Dihidrobenzofuranos. |
ATE231501T1 (de) * | 1995-05-18 | 2003-02-15 | Altana Pharma Ag | Phenyldihydrobenzofurane |
-
1996
- 1996-05-20 DK DK96915194T patent/DK0771794T3/da active
- 1996-05-20 JP JP53470896A patent/JP4172817B2/ja not_active Expired - Fee Related
- 1996-05-20 EP EP96915194A patent/EP0771794B1/en not_active Expired - Lifetime
- 1996-05-20 DE DE69636086T patent/DE69636086T2/de not_active Expired - Fee Related
- 1996-05-20 ES ES96915194T patent/ES2258775T3/es not_active Expired - Lifetime
- 1996-05-20 AT AT96915194T patent/ATE325110T1/de not_active IP Right Cessation
- 1996-05-20 WO PCT/JP1996/001327 patent/WO1996036624A1/ja active IP Right Grant
- 1996-05-20 AU AU57029/96A patent/AU705690B2/en not_active Ceased
- 1996-05-20 PT PT96915194T patent/PT771794E/pt unknown
- 1996-05-20 CN CNB961905298A patent/CN1163493C/zh not_active Expired - Fee Related
- 1996-05-20 CA CA002195755A patent/CA2195755A1/en not_active Abandoned
- 1996-05-20 KR KR1019970700326A patent/KR100445356B1/ko not_active IP Right Cessation
-
1997
- 1997-01-14 NO NO19970151A patent/NO317631B1/no unknown
- 1997-11-28 HK HK97102285A patent/HK1000785A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK0771794T3 (da) | 2006-09-11 |
KR100445356B1 (ko) | 2004-11-12 |
JP4172817B2 (ja) | 2008-10-29 |
EP0771794A1 (en) | 1997-05-07 |
EP0771794A4 (en) | 1998-09-02 |
DE69636086D1 (de) | 2006-06-08 |
DE69636086T2 (de) | 2006-11-30 |
AU5702996A (en) | 1996-11-29 |
KR970704724A (ko) | 1997-09-06 |
WO1996036624A1 (fr) | 1996-11-21 |
NO970151L (no) | 1997-03-06 |
HK1000785A1 (en) | 2006-06-30 |
AU705690B2 (en) | 1999-05-27 |
ATE325110T1 (de) | 2006-06-15 |
NO970151D0 (no) | 1997-01-14 |
PT771794E (pt) | 2006-09-29 |
ES2258775T3 (es) | 2006-09-01 |
EP0771794B1 (en) | 2006-05-03 |
CN1154697A (zh) | 1997-07-16 |
CA2195755A1 (en) | 1996-11-21 |
CN1163493C (zh) | 2004-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO317631B1 (no) | Oksygeninneholdende heterocykliske forbindelser | |
US6514996B2 (en) | Derivatives of benzofuran or benzodioxole | |
AU2002323787B2 (en) | Spiro compounds | |
TWI386405B (zh) | 咪唑衍生物 | |
DE69837346T2 (de) | Anilidderivate, deren herstellung und verwendung | |
EP1807396B1 (en) | 2-aminopyridine compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease | |
AU2022204071B2 (en) | Antibacterial compounds and uses thereof | |
EP1501803A2 (en) | Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity | |
CA3172478A1 (en) | Bcl-2 inhibitor | |
DE69918695T2 (de) | Sauerstoffhaltige heterocyclische verbindungen | |
JP2011521888A (ja) | グレリン受容体の調節因子としてのn−フェニルヒドラジド誘導体 | |
AU2017201415C1 (en) | Process for the preparation of c-fms kinase inhibitors | |
EP0943613A1 (en) | Oxygenic heterocyclic compounds | |
WO2007126041A1 (ja) | ベンゾイソオキサゾール化合物 | |
WO2014181788A1 (ja) | α-置換グリシンアミド誘導体 | |
CA3116506C (en) | Pyrrolo-pyridazine derivatives as muscarinic m1 receptor positive allosteric modulators | |
CA3160801A1 (en) | Novel functionalized lactams as modulators of the 5-hydroxytryptamine receptor 7 and their method of use | |
JP3553560B2 (ja) | 新規スピロ化合物 | |
KR19990067445A (ko) | 3-히드록시-피페리딘메탄올 유도체의 에스테르 | |
EA040011B1 (ru) | Антибактериальные соединения и их применение | |
KR20000011120A (ko) | 벤조퓨란카르복사미드 및 이들의 치료학적 용도 |